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ABSTRACT

THE EFFECTS OF WHOLE LIFE, LOW DOSE CADMIUM EXPOSURE ON
HIGH FAT DIET-INDUCED NONALCOHOLIC FATTY LIVER DISEASE AND
THE ROLE OF ZINC

Jamie L. Young
November 12, 2020

Nonalcoholic fatty liver disease (NAFLD) is a major global public health concern
affecting more than 25% of the world’s population. Although obesity is a major risk
factor for NAFLD, it cannot account for many cases, indicating the importance of
other factors such as sex and environmental exposures. Cadmium exposure is
implicated in the development of NAFLD; however, the influence of early-life, in
utero cadmium exposure on the development of diet-induced NAFLD is poorly
understood. Therefore, we developed an in vivo, multiple-hit model to study the
effect of whole-life, low-dose cadmium exposure on high fat diet (HFD)-induced
NAFLD. Additionally, we investigated the impact of dietary zinc supplementation
on disease outcome as both obesity and cadmium disrupt zinc homeostasis and
zinc deficiency is common in NAFLD patients. Adult male and female C57BL/6J
mice fed normal diets (ND) were exposed to 0, 0.5 or 5 ppm cadmium-containing
drinking water for 14 weeks before breeding. At weaning, offspring were fed ND or
HFD and continued on the same drinking water regimen as their parents. Male
vi

offspring were further subdivided into diets containing 30 or 90 mg zinc/4057 kcal,
representing normal and zinc supplemented diet, respectively. Cadmium exposure
altered HFD-associated weight gain and insulin resistance in males, but not
females. In males only, cadmium exposure altered HFD-induced liver injury and
NAFLD. Specifically, 0.5 ppm cadmium exposure rescued the adverse health
effects of HFD while 5 ppm cadmium exposure exacerbated outcomes. Further,
HFD blunted the response of metallothionein in mice exposed to 5 ppm cadmium
but enhanced the response in male mice exposed to 0.5 ppm cadmium, suggesting
a possible mechanism for cadmium altering HFD-induced NAFLD. Zinc
supplementation rescued the adverse effects cause by HFD and 5 ppm cadmium
exposure. Interestingly, in 5 ppm cadmium-exposed, HFD-fed female mice hepatic
zinc levels were similar to levels in males after zinc supplementation. Overall,
results from this study confirm the multi-hit nature of NAFLD, show whole life, low
dose cadmium exposure alters HFD-induced NAFLD, and suggest a potential
therapeutic role for zinc. Furthermore, this study highlights the importance of sex
as a risk factor in disease development.
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CHAPTER 1: INTRODUCTION

Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of
chronic liver disease with a global prevalence of between 25-45% (Rinella, 2015;
Younossi et al., 2018). In the United States, an estimated 35,000 people die
annually as a result of NAFLD-related complications (Paik et al., 2019).
Unfortunately, the prevalence of NAFLD has almost doubled over the past twenty
years and remains on the rise (Welsh et al., 2013); increasing in parallel with two
well-characterized risk factors of chronic liver disease: obesity and diabetes
(Williams et al., 2011; Chalasani et al., 2012). In fact, between 75 and 100 million
people in the U.S. are likely to have NAFLD, based on the estimation that 68% of
the adult population in U.S. is either overweight or obese (Rinella, 2015).
First described in 1980, NAFLD presents with a wide clinical spectrum of
outcomes involving excessive fat accumulation in the liver (fat deposits in >5% of
hepatocytes) not due to alcohol consumption (Rinella, 2015). Histologically,
NAFLD is divided into two categories: nonalcoholic fatty liver (NAFL) and
nonalcoholic steatohepatitis (NASH). Patients in the first category (NAFL) present
with simple steatosis while patients in the second category (NASH) present with
cellular damage and inflammation (Ludwig et al., 1980; Kleiner et al., 2005; Rinella,
2015). The spectrum of disease outcomes range from NAFL to NASH to cirrhosis,
1

and ultimately progression to hepatocellular carcinoma (Byrne and Targher, 2015;
Asrih and Jornayvaz, 2015). Approximately, 25% of subjects will progress from
simple steatosis on to more severe, chronic liver injury (Rinella, 2015; Buzzetti et
al., 2016), highlighting that the progression of NAFLD is complex and multifactorial.
Initially, to explain disease progression, a ‘two hit’ hypothesis was
formulated by Day and James (1998) suggesting a factor such as obesity serves
as a ‘first hit’ which sensitizes the liver to further insult, with a ‘second hit’ causing
disease progression from NAFL to NASH. However, over the past 20 years it has
become clear that the numerous molecular and metabolic changes that take place
throughout NAFLD progression are inadequately explained by the ‘two hit’
hypothesis, making way for the current ‘multiple hit’ hypothesis (Buzzetti et al.,
2016). As such, disease progression is determined by multiple parallel factors
including diet, genetics, sex and environmental factors (Figure 1.1).

Obesity and High Fat Diet (a first hit)
Obesity is a major public health concern affecting over 312 million people
worldwide. By the year 2050, the number of obese individuals in the United States
alone is expected to double (Fakhouri et al., 2013). A chronic imbalance of calorie
intake and calorie expenditure result in larger and more numerous fat cells in the
body, and subsequently obesity (Smilowitz et al., 2010). One of the major variables
contributing to obesity is consumption of high fat diets (Golay and Bobbioni, 1997),
which have become easily accessible and served in large portions and contribute
to today’s “obesogenic environment” (Poston and Foreyt, 1999).

2

Figure 1.1 ‘Multiple hit’ hypothesis of NAFLD progression. NAFLD is a
spectrum of diseases ranging from simple lipid accumulation to cirrhosis and
ultimately hepatocellular carcinoma. NAFLD progression is complex and
multifactorial. The ‘multiple hit’ hypothesis suggest disease progression is
determined by multiple parallel factors including obesity, insulin resistance,
genetics, sex and environmental exposures. Red arrows indicate disease
progression. Green arrows indicate disease reversibility.
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In humans, high fat diets easily induce obesity (Hariri and Thibault, 2010).
In fact, epidemiological studies in the United States, Canada and China have all
shown the incidence of obesity increases in parallel with increases in dietary fat
consumption (George et al., 1990; Popkin et al., 1993; Saris et al., 2000; Tucker
et al., 1992). Since the early 1950’s, when Fenton and Dowling (1953) created the
first dietary obesity model using a high fat diet in rats, animal models have been
widely utilized for experiments on dietary obesity (Hariri and Thibault, 2010).
Animal models of dietary obesity have allowed for the advancement of our
understating of several health conditions in which obesity is a major risk factor
including type 2 diabetes, hypertension and NAFLD (Ogden et al., 2012).
Although obesity is the primary risk factor for the development of NAFLD,
approximately 20% of normal weight people develop the disease, indicating other
risk factors are involved (Younossi et al., 2018). One such risk factor is exposure
to the non-essential metal cadmium, consistent with the fact the liver is a major
target organ of cadmium toxicity and accumulation (Arroyo et al., 2012).

Cadmium (a second hit)
Cadmium is a naturally occurring heavy metal with no known biological
function in humans and has been recognized as an occupational and
environmental risk factor for decades (ATSDR, 2012; Tinkov et al., 2017). Ranking
number 7 on the Agency for Toxic Substances and Disease Registry list of
environmental chemical hazards (ATSDR, 2012), cadmium is one of the most
common and detrimental metals present in our environment (Jacobo-Estrada et
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al., 2017). Approximately 25,000 tons of cadmium are naturally released into the
environment annually (Fatima et al., 2019). For example, natural releases of
cadmium into the air occur through volcanoes and forest fires while releases into
rivers and water bodies occur through the weathering of rocks (Fatima et al., 2019).
Additional releases of cadmium into the environment occur through human activity.
Although cadmium was discovered in 1817, it was not utilized commercially
until the late 19th century when it was used primarily in paint pigments (Llewellyn,
1994; IARC, 1993). Over the last century, exposure to cadmium has dramatically
increased (IPCS, 1992) due to its use in the production of batteries, pigments and
plastics. Anthropogenic sources of cadmium include mining, burning of fossil fuels
and incineration of household wastes, all of which play a significant role in
generating concentrated sources of cadmium and releasing it into the environment
(Jarup and Akesson, 2009). According to the Environmental Protection Agency
(EPA) cadmium has been found in 1,014 of the 1,669 current or former sites on
the National Priorities List (NPL) of hazardous waste sites. Although these sites
are destined for long-term clean-up, they pose a dangerous source of cadmium
exposure (ATSDR, 2012).
Cadmium released into the soil and water can accumulate in plants and
organisms that subsequently enter the food supply. Therefore, ingestion of
contaminated food and water are the primary source of cadmium exposure in the
non-smoking, general population with an average daily intake of between 4 and 26
μg/day (Choudhury et al., 2001; Martorell et al., 2011; Kim et al., 2018). One of the
most dangerous characteristics of cadmium is that it is a cumulative toxicant in
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which the body burden increases with age. The biological half-life of cadmium is
between 4 and 37 years, depending on the organ (ATSDR, 2012). The kidney and
the liver are the primary target tissues for cadmium accumulation accounting for
approximately 50% of the body’s cadmium burden (HSDB, 2006).
Cadmium has similar physical and chemical properties to essential divalent
metals such as zinc, iron and calcium. Therefore, through the process of ionic and
molecular mimicry, cadmium enters cells without the need of its own specific
transport proteins (Arroyo et al., 2012; Vesey, 2010). For example, studies have
shown cadmium ions use the divalent metal transporter 1 (DMT1, protein encoded
by the gene SLC11A2) as well as the metal transporter 1 (MTP1, protein encoded
by the gene SLC40A1) for cellular transport, both found on the membrane of the
enterocytes lining the intestinal wall (Ryu et al., 2004; Arroyo et al., 2012) (Figure
1.2). Furthermore, the absorption and tissue distribution of cadmium has been
shown to be mediated by a channel-like calcium transport (CaT1, encoded by the
gene TRPV6) which is used for intestinal absorption of calcium (Min et al., 2008).
Once absorbed through the intestinal tract, cadmium readily binds albumin
and is delivered by portal circulation to the liver. The sinusoidal capillaries
responsible for the uptake of cadmium into hepatocytes have membranes lined
with DMT-1 as well as Zrt-, Irt-related proteins (ZIP) 8 and 14 (encoded by the
genes SLC39A8 and SLC39A14, respectively), which are involved in zinc and iron
transport, respectively (Fujishiro et al., 2009; Liuzzi et al., 2006). Once inside
hepatocytes, cadmium avidly binds to proteins containing sulfhydryl groups
including glutathione (GSH) and with high affinity for metallothionein (MT). As an
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Figure 1.2. Cadmium disposition after oral exposure. Simplified schematic of
cadmium absorption and distribution via ionic and molecular mimicry to the liver
and kidney, the target organ of cadmium accumulation and toxicity, after oral
ingestion. Cd = cadmium, DMT = divalent metal transporter, MTP = metal transport
protein 1, CaT1 = channel-like calcium transport 1, ZIPs = Zrt-, Irt-related proteins,
GI = gastrointestinal, MT = metallothionein, GSH = glutathione.
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initial step in the detoxification process, cadmium binds to GSH and is excreted
into the bile via the canalicular glutathione transport system where it is mainly
excreted into the feces (Kurowska and Bal, 2010). However, cadmium has a strong
binding affinity for MT, which it preferentially binds to in the liver, serving as both a
method of detoxification and tissue retention, playing a key role in cadmium’s long
biological half-life (~ 20 years) in the liver (ATSDR, 2012; Arroyo et al., 2012).
In scenarios of chronic cadmium exposure, the cadmium bound MT
complexes formed in the liver are released from damaged hepatocytes into the
blood stream (Klassen et al., 2009). The cadmium-MT complexes are filtered by
the kidney, and subsequently reabsorbed into the renal proximal tubule cells.
Cadmium is then eliminated from the body in urine at a very slow rate thus
contributing to its long half-life. In addition, urinary cadmium levels are used as
markers of chronic cadmium exposures whereas blood cadmium levels are
considered to be more an indication of acute exposures (Vacchi-Suzzi et al., 2016).
The majority of toxicological research has focused on cadmium’s role as a
nephrotoxin and carcinogen. However, more recent studies show exposure to low
level, environmental cadmium correlates with the development of several
metabolic diseases, including type 2 diabetes, hypertension and NAFLD (Hyder et
al., 2013 ; Padilla et al., 2010; Little et al., 2020).
As a major site of cadmium accumulation, it is not surprising that the liver is
a target organ of cadmium toxicity. In animal models of liver failure, cadmium
exposure is well known to induce inflammation, apoptosis and liver cell
regeneration (Habeebu et al., 2000). These models, however, were designed to
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investigate the impacts of cadmium at high acute exposures, and did not take into
consideration the impact of lower, environmental exposures on liver disease. As
such, more recent in vivo studies have revealed low dose exposure to cadmium
dysregulates NAFLD-related metabolic pathways, disrupts essential metal
homeostasis and increases liver and serum triglycerides (Go et al., 2015; Zhang
et al., 2015; Young et al., 2019). In addition, environmental cadmium exposure has
been associated with hepatic necroinflammation, NAFLD and NASH in men and
necroinflammation women (Hyder et al., 2013). Despite these research advances,
our understanding of cadmium’s impact on the development and progression of
NAFLD is insufficient and unclear.
Our understanding of the impact of cadmium exposure on obesity is also
unclear. Epidemiologically, the existing data associating cadmium exposure with
obesity are contradictory (Tinkov et al., 2017). In particular the existing data vary
between positive (Akinloye et al., 2010; Padilla et al., 2010) and negative
associations (Tellez-Plaza et al., 2013; Nie et al., 2016) with some studies showing
no significant impact (Kelishadi et al., 2013; Gonzalez-Reimers et al., 2014). The
inconsistencies in the epidemiological findings may in part be explained by
differences in the levels of cadmium exposure, variability in analytical methods and
the use of different biological markers (i.e. nails, blood, urine, hair).
Results from laboratory studies are more consistent, showing that cadmium
exposure alone does not result in obesity but does adversely affect adipose tissue
physiology (i.e. decreased leptin, adiponectin, and insulin receptor number and
density) (Levy et al., 2000; Fickova et al., 2003; Kawakami et al., 2013). The
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altered adipose tissue physiology is speculated to increase the predisposition to
metabolic diseases, such as NAFLD, through increased insulin resistance and an
overall induction of a metabolic profile consistent with obesity (Simmons et al.,
2014; Tinkov et al., 2017).
Although it is well known that consumption of a high fat diet contributes
greatly to obesity, few studies have directly investigated the relationship between
cadmium and high fat diet in disease initiation and progression. Zhang et al. (2020)
showed combined exposure to low levels of cadmium and high fat diet adversely
affected bone quality. Another study showed a combination of high cholesterol diet
and cadmium resulted in cardiac fibrosis and increased risk of heart failure
(Türkcan et al., 2015). Our lab has recently shown that cadmium and high fat diet
work together to further disrupt essential metal homeostasis (Young et al., 2019).
Although informative, these studies highlight major knowledge gaps in our
understating of the effects of cadmium on high fat diet induced-diseases, including
NAFLD.

Sex (a third hit)
As previously mentioned and according to the “multiple hit” hypothesis,
NAFLD progression is determined by multiple factors acting in parallel. In addition
to diet and environmental exposures such as cadmium, recent attention was
turned to sex as a biological variable and risk factor. In fact, NAFLD is a sexually
dimorphic disease, occurring more often and with greater severity in men than in
women (Hyder et al., 2013). These results have been recapitulated in animal
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studies (Lonardo et al., 2019). However, little attention is given to the sexualdimorphism of the multiple risk factors involved in disease etiology. For example,
in addition to being a major risk factor for NAFLD, obesity itself is also a sexually
dimorphic disease from which females are more protected than males, at least
before menopause (Pettersson et al., 2012; Palmer and Clegg, 2015; Salinero et
al., 2018). After menopause, the prevalence and severity of obesity becomes
greater in women (Hales et al., 2020).
These epidemiological outcomes were recently recapitulated in an in vivo
study by Salinero et al. (2018). This study showed high fat diet-induced obesity in
juvenile mice (administered at 6 weeks of age for 12 weeks) increased weight gain
and cause glucose intolerance to a greater extent in males compared to females.
However, in an aged mouse (high fat diet administered at 32 weeks of age for 12
weeks), the sex differences were reversed with greater weight gain and glucose
impairment in female mice. The mechanism for age-dependent sex differences in
obesity are largely thought to be the result of hormones (Salinero et al. 2018);
however, further investigation is needed to understand the sex-dependent
influence of these hormones on diet-induced diseases, including NAFLD.
Sex-dependent differences also occur in response to environmental stress,
such as exposure to metals. There is increasing evidence that the adverse health
effects associated with exposure to toxic metals manifest differently in women and
men due to variation in exposure, kinetics, mode of action (Vahter et al., 2007). In
the case of cadmium exposure, the body burden of the metal is much greater in
women compared to men. Based on reports from occupational, high dose
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exposures, adverse health effects associated with cadmium are more common in
women; however these reports are generally in post-menopausal, elderly women
(Wang et al., 2003; Vahter et al., 2007; Akesson et al., 2005). In a more recent
study, Hyder et al. (2013) showed that lower, environmental exposure to cadmium
was associated with necroinflammation, NAFLD and NASH in men and only
necroinflammation in women of reproductive age. Although there is clear evidence
for sex differences in cadmium disposition and toxicity, the underlying mechanisms
remain unclear. Furthermore, how sex influences the multiple factors (diet and
environmental exposures) associated with NAFLD progression, in parallel,
remains to be investigated.
In fact, the effect of sex on the combined exposure of cadmium and high fat
diet have only been reported by our lab. Liang et al (2019) showed exposure to
low doses of cadmium (0.5 and 5 ppm in drinking water) combined with postweaning high fat diet for 10 weeks resulted in exacerbated high fat diet-induced
heart hypertrophy in female mice, but not male mice. Using the same model, we
reported cadmium exposure combined with post-weaning high fat diet for 24 weeks
altered essential metal homeostasis in the liver and kidney (Young et al., 2019).
Additionally, we found significant cadmium- and high fat diet-dependent sex
differences in essential metal distribution, which may contribute to differences
observed in obesity-associated pathologies between males and females. The
results from these two studies lay the foundation for future studies investigating
how sex, diet and environmental exposure work in parallel to influence disease
progression.
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Developmental Origins of Health and Disease (an important factor)
In relation to the “multiple hit” hypothesis, another factor contributing to
disease development and progression is that of chronicity and the timing. As such,
the focus of developmental toxicology has shifted from studying the effects of
toxicant-induced malformations to understanding how non-overtly toxic exposures,
in utero, result in increased susceptibility to diseases in adulthood. A variety of
terms have been used to describe this novel area of research including “fetal
origins of disease”, “fetal beginnings of adult disease”, “fetal basis of adult disease”
and the “developmental origins of adult disease”. However, although not
established as official terminology, the term Developmental Origins of Health and
Disease (DOHaD) is most commonly used (Barker, 2007; Heindel et al., 2017).
Originating in the 1990s, the DOHaD hypothesis suggests that exposures to
environmental stressors during sensitive stages of human development (in utero
and early childhood) increases susceptibility to adverse health outcomes in
adulthood (Barouku et al., 2012; Gluckman et al., 2010; Thayer et al., 2012).
The Dutch famine is one of the earliest documented examples of prenatal
environmental factors being associated with disease development in adulthood
(Painter et al., 2005). Toward the end of WWII, during the winter of 1944-1945, the
Dutch government implemented a railway strike with the intent of halting transport
of German troops and reinforcements, thereby aiding the Allied Forces. In
retaliation, the German government cut off food and fuel shipments to the Germanoccupied areas of the western Netherlands. As a result, the daily rations for the
general adult population dropped from 1800 calories to < 1000 calories/day. From
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this unfortunate event came the Dutch famine birth cohort study (Painter et al.,
2005). Although the offspring of women who were pregnant during the famine were
small for gestational age, in adulthood this cohort had an increased incidence of
obesity (Ravelli et al., 1999), diabetes (de Rooij et al., 2006; van Abeelen et al.,
2012), and cardiovascular disease (CVD) (Roseboom et al., 2000).
In the decades following the Dutch famine there have been numerous
studies, performed in both humans and animals, that suggest that in utero
exposures to environmental stressors, such as poor nutrition or exposure to
environmental chemicals, contribute to the initiation, and/or exacerbation of
chronic adult diseases such as CVD (Barker and Osmond, 1986; Barker et al.,
1989; Barker et al., 1993) and cancer (Newbold and McLachlan, 1996; Waalkes et
al., 2003). In 1986, Barker and Osmond observed that the same regions in England
with high rates of low-birthweight induced infant mortality had the highest rates of
death associated with coronary artery disease decades later (Barker and Osmond,
1986). It is this observation that initiated the “fetal basis for adult disease”
hypothesis, also known as the “Barker Hypothesis”.
Although many of the supporting studies that followed Barker’s observation
were focused on the effects of altered nutrition in utero, there has been growing
evidence that other factors including sex and environmental exposures increase
susceptibility to the development of chronic adult diseases (Heindel et al., 2015;
Jazwiec and Sloboda, 2019), such as NAFLD. In fact, in models of maternal high
fat diet feeding, adverse outcomes, such as increased hepatic triglycerides and de
novo lipogenesis, are more prominent in male offspring than female offspring and
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lead to the development of NAFLD in male, but not female offspring (Baylo et al.,
2010; Strakovsky et al., 2014; Li et al., 2015).
The influences of sex, as a biological factor, on the DOHaD hypothesis is
become increasingly recognized. Stress, nutritional insults, and environmental
chemical exposures during development can result in sex-specific effects (Heindel
et al., 2015; Jazwiec and Sloboda, 2019). The long term impacts of adversity in
early life are largely thought to operate through epigenetic mechanisms such as
altered DNA methylation patterns, which also varies between males and females
(Martin and Fry, 2018). For example, there are baseline differences in the
methylation patterns of the placentas from male and female pregnancies (Martin
et al., 2017). Many of these baseline differences are associated with transport and
metabolism of environmental contaminants and thus may provide valuable insight
into sex-dependent differences observed in environmental contaminantassociated health effects. Indeed, sex-specific differences in methylation patterns
associated have been observed with a number of environmental contaminants,
including cadmium (Huen et al., 2014; Alegría-Torres et al., 2016; Kippler et al.,
2013).
Due to the widespread production and use of metals, in parallel with the
knowledge that metals can be passed from mothers to offspring via placenta
and/or breast milk, concern has risen about prenatal exposure to metals and the
long-term adverse health implications (Wang et al., 2014; Young et al., 2018). For
some metals, such as arsenic, the connection between in utero exposures and
increased risk of disease development in adulthood, including NAFLD, is evident
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in both human and animal studies (Young et al., 2018); however, for other metals,
such as cadmium, this connection remains unclear.
In adults, the association between chronic cadmium exposures and
development of adverse health effects such as renal toxicity, CVD and cancer is
well documented (Jarup and Akesson, 2009; Nawrot et al., 2010). In children, preand postnatal exposure to cadmium is associated with reduced birthweight,
impaired fetal growth, trace element deficiencies and congenital malformations (AlSaleh et al., 2014; Hudson et al., 2019; Jin et al., 2016; Kippler et al., 2012; Taylor
et al., 2016). Although it is well documented that prenatal exposure to cadmium is
associated with adverse effects on child health and development, the implication
for long term health remain elusive (Figure 1.3). Few studies have considered the
possibility that prenatal cadmium exposure may reprogram an individual to be
more susceptible to pathologies later in life.
Epidemiologically, the link between early-life cadmium exposures and
increased risk for adult diseases remains to be explored. Experimentally,
researchers have just begun to develop models to study the impact of early life
cadmium exposure on disease development later in life. Hudson et al. (2019)
investigated the impact of maternal cadmium exposure on cardiovascular changes
in offspring at birth or after 6 months of age. This study showed maternal cadmium
exposure was associated with a hypertensive phenotype in adult female, but not
in male mice (Hudson et al., 2019). Furthermore, as mentioned above, our lab has
reported whole life exposure to cadmium, starting in utero, enhances diet-induced
cardiac hypertrophy in female mice as well as disrupts essential metal
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Figure 1.3. Summary of the effects of placental cadmium accumulation and the
non-lethal adverse birth outcomes that may lead to increased susceptibility of
disease development in adulthood (Young and Cai, 2020).
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homeostasis in a sex-specific manner (Liang et al., 2019; Young et al., 2019).
While results from these studies provide critical insight into the importance of early
life exposure to cadmium on the development of disease later in life, empirical
evidence is still needed to strengthen these observations in both animal models
and prospective birth cohort studies in humans. Additionally the impact of early life
cadmium exposure on the development of high fat diet-induced NAFLD remains
unexplored.

Summary and dissertation aims
The purpose of this dissertation is address these key data gaps and
investigate the impact of whole life, low-dose cadmium exposure on high fat dietinduced non-alcoholic fatty liver disease (NAFLD). NAFLD affects more than 20%
of the adult population in the United States (Younossi et al., 2018). Although
obesity is a major risk for the development of NAFLD, it does not account for all
cases (Younossi et al., 2018). Thus, other risk factors, including genetics and/or
environmental exposures, play an important role. Previous studies have correlated
environmental exposures to the nonessential metal cadmium with the
development of NAFLD (Padilla et al., 2010). However, the mechanisms by which
cadmium influences the initiation, progression and exacerbation of NAFLD
induced by high fat diet are not well understood. In addition, these studies do not
consider the fact that environmental exposures can be life-long and
multigenerational nor do they take into account that the risk of developing
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adulthood disease is correlated with adverse stimuli in utero, resulting in
permanent physiological and metabolic changes.
Therefore, we developed a multi-hit model, considering diet, sex and
environmental exposure, to study the effects of whole life exposure to low dose
cadmium on the development of high fat diet-induced NAFLD. Our central
hypothesis is that whole life, chronic cadmium exposure exacerbates high fat dietinduced NAFLD in males more than females. This hypothesis will be tested with
three Specific Aims:

Aim 1: Measure the impact of whole-life, chronic cadmium exposure on HFDinduced NAFLD.
In this aim, a mouse model of cadmium exposure and high fat diet induced
NAFLD will be established and used to test the central hypothesis. Exposure of
parental mice will be for 18 weeks. Male offspring will be exposed to cadmium in
utero and, after weaning, continued on normal or high fat diet, with or without
cadmium for 24 weeks. The model will be used to assess key endpoints reflecting
metabolic alterations and hepatic toxicity, characteristic of NAFLD at the whole
animal, tissue and molecular levels.

Aim 2. Show zinc supplementation protects against cadmium-enhanced, high fat
diet-induced NAFLD.
Our lab showed zinc supplementation rescues cardio-renal hypertrophy in
high fat diet-fed mice (Wang et al., 2017). Others showed zinc supplementation
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attenuates high fat diet-induced NAFLD in rats (Shidfar et al., 2018). Therefore,
this aim will examine dietary zinc supplementation as a treatment approach and
test the hypothesis that zinc supplementation protects against cadmiumexacerbated, high fat diet-induced NAFLD. This aim will be investigated using the
same exposure paradigm established in the first aim. However, after weaning male
offspring will be further divided into normal diet and high fat diet groups receiving
either normal zinc or supplement zinc in their diets. At the whole animal, tissue and
molecular levels the impact of altered dietary zinc on key endpoints characteristic
of NAFLD will be assessed.

Aim 3. Determine the role of sex in cadmium-enhanced, high fat diet-induced
NAFLD.
The prevalence and manifestation of numerous metabolic diseases are
sexually-dimorphic, including NAFLD (Ballestri et al., 2017; Lonardo et al., 2019).
Additionally, there is increasing evidence that the health effects of toxic metals,
including cadmium, are different between men and women (Vahter et al., 2007).
We recently showed that low-dose cadmium exposure induces cardiac
hypertrophy and fibrosis in female but not male mice (Liang et al 2019). Therefore,
this aim will examine sex as a risk factor and test the hypothesis that female mice
are protected against cadmium-enhanced, high fat diet-induced NAFLD. A female
mouse model of NAFLD and cadmium exposure will be established, mirroring the
model created in the first aim. The model will test the hypothesis that female sex
protects against cadmium enhanced, high fat diet-induced NAFLD.
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CHAPTER 2: MATERIALS AND METHODS

This section contains the materials and methods for all three dissertation aims.

Animal models and exposures
Eight week old male (n=19) and female (n=51) C57BL/6J mice were
purchased from Jackson Laboratory (Bar Harbor, ME). Mice were maintained on
a 12 hour light/dark cycle at 25°C in a pathogen-free barrier facility accredited by
the Association for Assessment and Accreditation of Laboratory Animal Care. All
experimental procedures were approved by the University of Louisville’s
Institutional Animal Care and Use Committee. After one week of acclimation in the
barrier facility, diets were switched from standard laboratory chow to purified
normal mouse diet (ND, 10% kcal fat; Research Diets D14020202, New
Brunswick, NJ) to minimize the influence of metal contamination found in standard
laboratory chow on experimental outcomes (Kozul et al., 2008). At 9 weeks old,
mice were placed on a drinking water regimen of either tap water alone (control)
or cadmium containing water (0.5 or 5 ppm – final concentration). Cadmium
containing drinking water was prepared weekly from stock solutions of cadmium
chloride (Alfa Aesar, Haverhill, MA) made with deionized water and stored at
−80°C. Five ppm cadmium was used as a positive control because based on a
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survey of the literature, 5 ppm cadmium is one of the lower concentrations of
cadmium tested with results supportive of metabolic syndrome phenotypes. In
addition we used a ten times lower concentration of 0.5 ppm cadmium. According
to the Agency for Toxic Substances and Disease Registry (ATSDR) approximately
100 to 300 mg/kg cadmium (1 ppm = 1 mg/kg) is lethal to 50% of rodents after
acute oral exposure (ATSDR, 2012). Our oral exposures are less than 1% and
0.1% of this cadmium level.
At 10 weeks of age, mice were placed into mating groups (F0) (1 male to 2
or 3 females) within each drinking water exposure (Figure 2.1). Pregnant dams
continued on the drinking water regimen through weaning and offspring (F1) were
continuously exposed to the same concentration of cadmium as their parents after
weaning. At weaning, offspring were either fed the same ND as their parents or a
high fat diet (HFD, 60% kcal fat; Research Diets D14020205, New Brunswick, NJ).
Male mice were further grouped into diets containing 30 or 90 mg zinc/4057 kcal,
representing normal zinc (ZN) and zinc supplemented (ZS) diet, respectively.
(ND/ZS - Research Diets D14020203; Research Diets D14020206, New
Brunswick, NJ).
Food and deionized water were provided ad libitum. Body weights and
water consumption was recorded weekly. First litter animals were too few;
therefore, they were sacrificed and tissues stored for other possible studies. The
male and female parents (F0) who had been continuously exposed to cadmium in
their drinking water for 14 weeks (through the first mating and through the first
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Figure 2.1. Exposure paradigm. (A) Adult male and female C57BL/6J mice on
defined, diets were exposed to control drinking water, or water containing 0.5 or 5
ppm Cd for 14 weeks before being established into breeding pairs. Pregnant dams
and offspring were continuously exposed and continued on the same drinking
water regime as their parents after weaning. At weaning, offspring were also fed
either a normal or high-fat diet (ND or HFD, respectively) for 24 weeks. The same
paradigm was used in Aim 2 with the modulation of zinc in the diet. (B) One week
prior to sacrifice, IPGTT tests were performed and body composition determine by
DEXAscan (DS). IPGTT = intra-peritoneal glucose tolerance test, wks = weeks,
ZN = zinc normal diet, ZS = zinc supplemented diet.
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pregnancy) were placed into mating groups again (1 male to 2 or 3 females) to
produce a second litter. These second litter offspring were subjected to the same
exposure paradigm as the first litter and euthanized 24 weeks post-weaning
(details below).
Mice were anesthetized with an intraperitoneal injection of avertin (250
mg/kg). Blood was collected from the inferior vena cava prior to euthanasia via
exsanguination. Blood samples were centrifuged for 5 minutes at 6,000 rpm and
citrated plasma was stored at -80°C for further biochemical analysis. For each
mouse, liver weight was recorded and portions of liver tissue were snap-frozen in
liquid nitrogen, processed for RNA isolation, fixed in 10% neutral buffered formalin
for histology and immunohistochemistry, frozen-fixed in Tissue Tek OCTCompound (Sakura Finetek, Torrance, CA) or used for metals analysis. The liver
weight to tibia length ratio (liver weight in grams divided by tibia length in
millimeters) was used as an index of liver size changes.

Body composition
Although body mass index (BMI) continues to be the most widely used
measurement of obesity, it is a poor assessment of metabolic status and does not
take into consideration lean tissue mass (muscle mass), bone mineral content nor
distribution of fat mass (Heymsfield and Cefalu, 2013; Ponti et al., 2019).
Therefore, we used dual-energy X-ray absorptiometry scan (DEXAsan) technology
to more accurately and informatively assess body mass composition changes in
our animal model. A Lunar PIXImus Densitometer (GE Healthcare, Chicago, IL),
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provided by the University of Louisville Diabetes and Obesity Center Animal
Models and Phenotyping Core, was used to perform DEXAscans on randomly
selected mice from each exposure group. Briefly, mice were weighed then
anesthetized with 2-4% isoflurane in O2 by inhalation. The depth of anesthesia was
determined by response to toe pinch. Once under adequate anesthesia, the mouse
was placed on a specimen tray on the scanning platform with legs slightly
outstretched, tail curled around the left side of the mouse, straight spinal alignment
and head positioned to fit the nose within the nosecone (continued provision of
anesthesia). After ensuring the limbs and body of the mouse were in the predetermined outlines on the specimen tray, the animal ID, body weight, gender and
date of birth were entered into the software and the scan started (4-5 minutes). At
the end of the scan, mice were taken off the platform and placed into a “recovery
cage” and monitored. Using the PIXImus software, a manual analysis was
performed to adjust the region of interest (ROI) to exclude the head region, the
scan repositioned and data exported. Data output included body composition (%
fat), lean tissue mass (g), bone mineral density (BMD) (g/cm2) and bone mineral
content (BMC) (mg).

Glucose tolerance test
The intraperitoneal glucose tolerance test (IPGTT) measures the body’s
ability to clear an injected load of glucose. Dysregulation of glucose metabolism is
associated with the pathophysiology of many metabolic disorders, including
NAFLD (Chao et al., 2019). Mice were fasted for 6 hours, weighed and injected
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with a 2 g/kg glucose solution. Blood glucose levels were measured at 0 (preinjection), 15, 30, 60, and 120 minutes post-glucose injection using a FreeStyle
complete blood glucose monitor system (Abbott Diabetes Care Inc., Alameda, CA).
A time course of absolute blood glucose measurement and the area under the
curve (AUC) were determined for each animal.

Biochemical analysis
Plasma insulin levels were measured with the Ultra Sensitive Mouse Insulin
ELISA Kit (Crystal Chem, Elk Grove Village, IL) using the manufacturer’s
instructions for preparing samples and reagents for the wide range assay (0.1 12.8 ng/mL).
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are
released into the blood stream as a result of injury to the liver and are thus used
as clinical biomarkers of hepatic injury. Levels of plasma ALT and AST were
determined spectrophotometrically using InfinityTM ALT (GPT) and AST (GPO)
Liquid Stable Reagents (Thermo Fisher Scientific, Waltham, MA) per the
manufacturer’s instructions. Data Trol™ Normal and Abnormal Control Serum
were used as assay controls (Thermo Fisher Scientific, Waltham, MA).
Hepatic triglycerides (TG) were determined spectrophotometrically using
InfinityTM Triglycerides Liquid Stable Reagents (Thermo Fisher Scientific,
Waltham, MA) per the manufacturer’s instructions. A 200 mg/dL TG standard was
used as an assay control (Thermo Fisher Scientific, Waltham, MA). Liver tissue
(70-100 mg) was homogenized in a 2 mL, flat bottom microcentrifuge tube, on ice
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in 1 mL of 50 mM sodium chloride. For each sample, 500 μl of homogenate was
placed into a 15 mL conical tube with 4 mL of fresh extraction buffer (2 parts
Chloroform: 1 part Methanol) and vortexed for 2 minutes at room temperature.
Samples were then centrifuged at room temperature for 20 minutes at 1800 x g.
The volume of the clear, lower chloroform layer was recorded and 500 μL of the
chloroform layer was placed into a 2 mL, flat-bottom microcentrifuge tube. Samples
were placed in a chemical hood, uncapped, and allowed to evaporate overnight.
The next day, 500 μL of InfinityTM Triglycerides Liquid Stable Reagent (equilibrated
to room temperature) was added to each of the dried samples and vortexed for at
least 2 minutes. Samples were then incubated for 10 minutes at 37°C. At the end
of incubation, 200 μL of sample/reagent mix was added in duplicate to a 96 well
microplate and total TG measured with a plate reader at 500 nm.
Total hepatic cholesterol (TC) was determined spectrophotometrically using
InfinityTM Cholesterol Liquid Stable Reagents (Thermo Fisher Scientific, Waltham,
MA) per the manufacturer’s instructions. A 200 mg/dL TC standard was used as
an assay control (Thermo Fisher Scientific, Waltham, MA). Liver samples were
extracted and analyzed as described above for total hepatic triglycerides.

Histological analysis
Paraffin-embedded sections of liver (5 μm) were deparaffinized with xylene,
rehydrated with graded ethanol washes and stained with hematoxylin and eosin
(H&E) to assess overall hepatic structure. Pictures were taken on an Olympus
BX43 microscopy system using Olympus cellSense Imaging Software (Shinjuku
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City, Tokyo, Japan). Steatosis was scored as percent of liver cells in a 100x field
containing fat (<25% = 1+; <50% = 2+; <75 = 3+; >75% = 4+). For each animal,
ten 100x fields were scored. Histological evaluation of neutral lipids was done
using oil red O (ORO) (C26H24N4O), a fat soluble, diazole dye (Sigma Aldrich, St.
Louis, MO) (Mehlem et al., 2013). Fresh frozen liver sections (10 μm) were fixed
in 10% neutral buffered formalin for 20 minutes, rinsed with ddH2O, immersed in
freshly prepared 60% isopropanol for 2 minutes and stained with freshly prepared
ORO working solution (6 parts saturated Oil Red O isopropanol solution : 4 parts
ddH20) for 30 minutes at room temperature. ORO stained slides were then rinsed
with ddH20 and lightly stained with hematoxylin (10 dips), rinsed with distilled water
(10 dips), and rinsed (10 dips) in 3% acetic acid to remove access hematoxylin.
Slides were rinsed for 10 minutes in running tap water and mounted with glycerol.
The same day, ten 100x pictures were taken on an Olympus BX43 microscopy
system using Olympus cellSense Imaging Software (Shinjuku City, Tokyo, Japan).
Exposure time and gain settings were determined using a sample known to have
excessive ORO staining. Image J software (National Institutes of Health,
Bethesda, Maryland) was used to quantify the percent of area positively stained
with ORO.

Total RNA isolation, cDNA synthesis and qRT-PCR
Total RNA was isolated from liver tissues using STAT 60 (Amsbio LLC,
Abingdon, United Kingdom), following the manufacturer’s protocol for RNA
isolation. Briefly, tissue was homogenized on ice in 1 mL of STAT 60 reagent and
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allowed to sit at room temperature for 5 minutes before the addition of chloroform.
Sample homogenates were vortexed for 15 seconds, allowed to sit at room
temperature for 2 minutes, and centrifuged at 12,000 g for 15 minutes at 4°C. The
aqueous phase was transferred to a fresh tube, mixed with isopropanol, allowed
to sit at room temperature for 8 minutes and centrifuged at 12,000 x g for 10
minutes at 4°C. After centrifugation, the supernatant was carefully removed, not
disturbing the RNA precipitate on the bottom of the tube. The pellet was washed
with 75% ethanol and allowed to air dry in a chemical fume hood followed by the
addition of diethylpyrocarbonate (DEPC) treated RNase-free water to solubilize the
RNA. The quality and the concentration of the RNA was measured using a
NanoDrop ND-1000 spectrophotometer.
Using a Reverse Transcription System (Promega, Madison, WI), 1 μg of
total RNA was used to synthesize cDNA following the manufacturer’s instructions
with slight modifications. For each sample, a 20 μL reaction was prepared by
combining 10 mM dNTP mixture, Recombinant RNasin® Ribonuclease Inhibitor,
AMV Reverse Transcriptase, random primers and nuclease-free water with 1 μg
total RNA. For each reverse transcriptase reaction a no RNA control and a no
reverse transcriptase control were included. Quantitative RT-PCR reactions were
performed using TaqMan® RNA assays (Thermo Fisher Scientific, Waltham, MA).
TaqMan

gene

expression

assays

(GAPDH,

Mm99999915_g1;

MT1,

Mm00496660_g1; MT2, Mm04207591_g1; SCD-11, Mm00772290_m1; FASN,
Mm00662319_m1;

SREBF1,

Mm00550338_m1;

HMGCR,

Mm01282499;

HMGCS, Mm01304569_m1) were combined with Entrans 2x qPCR Probe Master
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Mix (ABclonal, Woburn, MA) and DEPC water to create a master mix for each
primer. The master mix was added in duplicate to a 96 well plate, followed by the
addition of the corresponding cDNA. For all qRT-PCR runs a no cDNA control was
included in addition to the no reverse transcriptase and no RNA controls produced
during cDNA synthesis. Reactions were performed on a LightCycler® 96 RealTime PCR Cycler (Roche, Basel, Switzerland) using the following conditions.
Samples were warmed up at 4.4°C/second until they reached 95°C at which point
they were held for 10 minutes, followed by 45 cycles of denaturing (10 seconds at
95°C) and annealing/extending (45 seconds at 60°C). Results are presented as
∆∆Ct values relative to unexposed, normal diet controls.

Protein extraction for western blot
Liver tissues (approximately 30 mg/liver) were homogenized on ice in lysis
buffer containing 50 mM Tris-HCl (pH 7.4), 1 mM 0.5 EDTA (pH 8.0, 50ug/mL
phenylmethylsulfonyl fluoride and Protease Inhibitor Cocktail (Sigma-Aldrich, St.
Louis, MO). After homogenization samples were placed on a rotating mixer for 4
hours at 4°C followed by centrifugation at 12,000 rpm at 4°C for 20 minutes.
Supernatant was carefully collected as to not disturb the pellet on the bottom of
the test tube and aliquoted into three fresh 1.5 mL Eppendorf tubes for storage at
-80°C until use. Prior to use, protein concentrations were quantified by the Bradford
assay (Bio-Rad protein assay dye reagent; Bio-Rad, Hercules, CA) using bovine
serum albumin (BSA) as the reference protein for creating a standard curve.
Samples were then boiled with 4x loading buffer and 50 mmol/L dithiothreitol for 5
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minutes at 95ºC and placed on ice. Nuclear protein was extracted using a Nuclear
Extraction Kit (Abcam, ab113474) following manufacturer’s instructions for tissue
samples.

Western blot analysis
Protein from the liver tissues were separated on a 10% sodium
dodecylsulfate/polyacrylamide gel electrophoresis (SDS-PAGE) gel at a constant
70 V until the bromophenol dye was approximately half way down the gel and then
increased to a constant 120 V until the tracking dye reached the bottom of the gel.
Protein was transferred to a 0.22 μM nitrocellulose membrane (Bio-Rad, Hercules,
CA) in transfer buffer containing 20 mM Tris base, 152 mM glycine and 20%
methanol for 90 minutes in a 4 ºC walk-in refrigerator at a constant 250 mA. At the
end of the transfer membranes were stained with Ponceau S (Sigma-Aldrich, St.
Louis, MO) to reversibly detect protein bands followed by washing 3x for 5 minutes
with tris buffered saline contain 10% tween-20 (TBST) (VWR, Radnor, PA).
Membranes were incubated in blocking buffer (5% milk and 0.5% BSA in TBST)
at room temperature for 1 hour, rinsed 2x for 5 minutes with TBST and incubated
in primary antibodies diluted in 5% BSA in TBST against SREBP-1 (Abcam 28481;
1:1000) and GAPDH (Santa Cruz sc-32233; 1:3000) overnight at 4ºC. Membranes
were washed 3x for 5 minutes with TBST and incubated with secondary
horseradish-peroxidase conjugated antibodies (Anti-mouse IgG 7076 or Antirabbit IgG 7074; Cell Signaling Technology, Danvers, MA) diluted 1:3000 in
blocking buffer for 1 hour at room temperature. Membranes were visualized using
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enhanced chemiluminescence (ECL) reagents and a ChemiDocTM Touch Imaging
System (Bio-Rad, Hercules, CA). The amount of protein was analyzed and
normalized against their respective loading controls using Image Lab analysis
software version 5.2.1 (Bio-Rad, Hercules, CA).

Western blot analysis for metallothionein
MT is a small molecular weight (~6 kDa), cysteine rich protein that requires
alternate western blot conditions compared to the general protocol described
above to ensure the metallothionein protein 1) does not form disulfide bonds with
itself or other cysteine rich proteins and 2) successfully transfers from the gel to
the membrane and is retained on the membrane for analysis. The transfer
conditions for MT are not appropriate for the detection of β-actin; therefore, 2
parallel gels are run under the same conditions except the gel for MT is transferred
to a nitrocellulose membrane in a 15% methanol, calcium chloride containing
buffer while the β-actin gel, run in parallel, was transferred in a 20% methanol
buffer without calcium chloride. MT protein analysis was calculated as the fold
difference relative to control (in the same membrane) with the β-actin membrane
serving only to confirm equal loading of the protein.
For each sample, dithiothreitol was added to the protein/lysis buffer mix to
a final concentration of 20 mM and incubated at 56 ºC for 30 minutes followed by
the addition of iodoacetamide (IAA) (Sigma-Aldrich, St. Louis, MO) to a final
concentration of 50 mM then incubated in the dark at room temperature for 1 hour.
IAA was added to covalently bind to the thiol groups of the cysteine residues on
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MT to hinder the formation of disulfide binds. Samples were centrifuged for 5
minutes at 800 rpm and supernatant collected, making sure not to disturb the pellet
at the bottom of the tube. Loading buffer (9 μL/sample) was added, samples
vortexed and boiled for 5 minutes at 95ºC and placed on ice. Samples were
subjected to electrophoresis on a 16% SDS-PAGE gel at a constant 100 V until
the tracking dye reached the bottom of the gel. Gels were incubated in freshly
made, ice cold transfer buffer containing 20 mM Tris base, 152 mM glycine, 15%
methanol and 2 mM calcium chloride, dihydrate for 15 minutes before transfer to
a 0.22 μM nitrocellulose membrane (Bio-Rad, Hercules, CA) at a constant 40 V for
90 minutes.
After the transfer, membranes were incubated with 2.5% glutaraldehyde
(Fisher Scientific, Waltham, MA) for 1 hour at room temperature to cross-link MT
onto the membrane, increasing its retention. Membranes were washed 2x for 5
minutes in phosphate buffered saline (PBS) followed by a 5 minute wash in 50 mM
ethanolamine (Sigma-Aldrich, St. Louis, MO) in PBS to quench any residual
glutaraldehyde. Membranes were blocked in freshly made 3% BSA in PBS for 90
minutes at room temperature followed by incubation with primary MT monoclonal
antibody (Dako M0639, clone E-9, Santa Clara, CA) diluted 1:1000 in 3% BSA in
PBS overnight at 4ºC.
The next day, membranes were washed 3x for 5 minutes with TBST and
incubated with secondary horseradish-peroxidase conjugated antibody (Antimouse IgG 7076; Cell Signaling Technology, Danvers, MA) diluted 1:3000 in 3%
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BSA in PBS for 1 hour at room temperature. Membranes were visualized as
described above.

Metals analysis
Each whole blood and liver sample (20-100 mg wet-weight) was digested
in 1 mL of 70% concentrated trace metal grade nitric acid in an 85°C water bath
for 4 hours. After digestion, samples were cooled to room temperature and filtered
using a 100 µm filter. Next, 34 mL of Milli-Q deionized water was added to each
sample bringing the final concentration of nitric acid to 2%. Metal levels were
assessed using an X Series II quadrupole inductively coupled plasma mass
spectrometry (ICP-MS) (Thermo Fisher Scientific) equipped with an ESI SC-2
autosampler (Elemental Scientific, Inc.) for sample injection. During sample
injection, internal standards including Bi, In, Li, Sc, Tb and Y (Inorganic Ventures)
were mixed with each sample for drift correction and accuracy improvement. Each
sample was analyzed three times and metal levels calculated and presented as
ng/g wet tissue. Anything less than the Intercept Concentration was considered
non-detectable.

Statistical analysis
Statistical analysis was performed using GraphPad Prism version 7
statistical software (GraphPad Software Inc., San Diego, CA). Results are reported
as the mean ± standard deviation (SD; n=2-12). Following two-way ANOVA
analysis to determine if there was significant interaction between diet and cadmium
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exposure, Bonferroni’s post hoc test was performed using a significance level of p
< 0.05. For Aim 1 and 3: *, p < 0.05 compared to group control; #, p < 0.05
compared to cadmium dose within diet group; @, p < 0.05 compared to
corresponding normal diet. For Aim 2: *, p < 0.05 compared to group control; #, p
< 0.05 compared to corresponding normal zinc diet; @, p < 0.05 compared to
corresponding normal diet.
For body weight, repeated measures analysis of variance (rANOVA), a
special case of linear mixed effect models, was used. In the rANOVA, the main
effects (Cd exposure, diet, Zn supplement, time in weeks) and their interactions as
fixed effects, and subject as random effects were included. The estimated fixed
effects, their standard errors, and p-values were used for statistical inferences.
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CHAPTER 3: RESULTS

Aim 1: Measure the impact of whole-life, chronic cadmium exposure on high
fat diet-induced NAFLD
Background
NAFLD is the most common cause of chronic liver diseases affecting more
than 25% of the world’s population (Younossi et al., 2018) and in the United States
alone, between 75 and 100 million individuals are afflicted with the disease
(Rinella, 2015). Obesity, a major public health concern affecting over 312 million
people worldwide, is one of the greatest risk factors for the development of NAFLD
(Fakhouri et al., 2013; Ogden et al., 2012; Ruhl and Everhart, 2015). In fact,
NAFLD is prevalent in over 90% of obese patients (Younossi et al., 2018).
Interestingly, up to 20% of NAFLD patients are considered to be of normal weight;
therefore indicating the influence of other risk factors in disease development such
as genetics and/or environmental exposures.
Even with advances in the field, the knowledge of the mechanism
underlying the development and pathogenesis of NAFLD remain incomplete. For
example, despite the increasing prevalence of NAFLD, most patients only present
with simple steatosis that never progresses to necroinflammation or subsequent
fibrosis and chronic liver disease (Buzzetti et al., 2016). Thus, suggesting that
addition to a first “hit” that induces steatosis (such as over consumption of a high
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fat diet) the progression of the diseases requires a second “hit” (such as an
environmental exposure), a hypothesis proposed by Day and James (2015)
(Nakamura and Teraichi, 2013).
Environmental exposure to the non-essential metal cadmium is implicated
in the development of several metabolic diseases, including NAFLD (Hyder et al.,
2013; Fatima et al., 2019; Little et al., 2020). The liver is a major target organ of
cadmium accumulation and although it is clear that chronic cadmium exposure
induces hepatotoxicity the mechanism(s) are still not fully understood (Järup et al.,
1998; Järup and Akesson, 2009). Limited studies correlating cadmium exposure
with metabolic diseases, such as NAFLD, do not take into account such
environmental exposures can be life-long and multigenerational nor do they take
into account the risk of developing adulthood diseases is correlated with adverse
stimuli in utero, resulting in permanent physiological and metabolic changes.
Additionally, the impact of whole life exposures to cadmium alone, or in conjunction
with high fat diet, on NAFLD have not been investigated. Therefore, we developed
an in vivo multiple-hit model to study the effect of whole life, low dose cadmium
exposure on high fat diet-induced NAFLD (Figure 3.1).
We adopted this multiple-hit model using a high fat diet to induce steatosis
in C57BL/6 mice exposed to cadmium starting in utero, and continuing through
adulthood. The C57BL/6 mouse strain is the most widely used nutritional model of
NAFLD (Aydos et al., 2019). NAFLD induction by a high fat diet in C57BL/6 mice
results in phenotypes similar to those observed in humans with NAFLD (i.e.
obesity,

37

Figure 3.1. Model of whole life exposure of male mice to cadmium and high
fat diet. (A) Adult male and female C57BL/6J mice on defined diets were exposed
to control drinking water, or water containing 0.5 or 5 ppm cadmium for 14 weeks
before being established into breeding pairs. Pregnant dams and male offspring
were continuously exposed and continued on the same drinking water regime as
their parents after weaning. At weaning, male offspring were also fed either a
normal or high-fat diet (ND or HFD, respectively) for 24 weeks. (B) One week prior
to sacrifice, IPGTT tests were performed and body composition determined by
DEXAscan (DS). IPGTT = intra-peritoneal glucose tolerance test, wks = weeks
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hyperglycemia and liver damage) and reflect the natural course of the disease in
humans (Nakamura and Teraichi, 2013; Aydos et al., 2019). Using this model, we
asked three primary questions: 1) Did our high fat diet model successfully induce
NAFLD?; 2) Did our cadmium exposure model result in hepatic cadmium
accumulation?; and 3). Did whole life exposure to low concentrations of cadmium
exacerbate high fat diet-induced NAFLD?

Findings
Characterization of the high fat diet model used to induce NAFLD
We first wanted to confirm our high fat diet model was successful. It is well
known that diets high in fat promote weight gain and obesity (Golay and Bobbioni,
1997). Although BMI is used as the leading measure of obesity, a number of
studies have shown this measurement has limited ability to accurately determine
body composition (Kennedy et al., 2009; Heymsfield and Cefalu, 2013; Ponti et al.,
2019). DEXAscan is considered a much more accurate measure of obesity,
providing fat, bone and lean tissue measurements (Shepherd et al., 2017).
Additionally, diets high in fat are a major risk for insulin resistance (Park et al.,
2001; Winzell et al., 2004) and increased blood sugar levels in combination with
increased insulin in the blood are indicators of insulin resistance (Bowe et al.,
2014). Furthermore, insulin resistance is a hallmark of NAFLD that greatly
influences disease progression (Manco, 2017). Therefore, we evaluated our model
with these four measures: Body weight, DEXAscan, IPGTT and plasma insulin.
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We tracked body weight gain over time and assessed body mass
composition with DEXAscan technology and found the expected outcomes; mice
fed high fat diet gained significantly more weight overtime (p = <0.001) (Figure
3.2A) and had greater percent fat and lean tissue mass compared to normal diet
fed mice (Figure 3.2B and E). The DEXAscan further showed consumption of high
fat diet did not impact bone mineral density or bone mineral content (Figure 3.2F
and G). Further indicative of a successful model, the diet high in fat significantly
increased blood glucose levels compared to normal diet fed animals (Figure 3.3A
and B) with a trend towards increased insulin in the plasma (Figure 3.3C)
suggesting the development of diet-induced insulin resistance
Next, we assessed the ability of our high fat diet model to induce NAFLD.
The ratio of liver weight at sacrifice to the length of the tibia is an indicator of
hepatomegaly (enlarged liver) and suggests hepatic damage. Elevated ALT and
AST, transaminases released into the bloodstream upon injury to the liver, are
widely used laboratory indicators of hepatocellular damage. Histologically, liver
injury can be further assessed by examination of hematoxylin and eosin (H&E)
stained paraffin embedded tissue for overall hepatic structure and oil red O staining
to determine the presence of fat, which is commonly confirmed with biochemical
analysis of hepatic triglyceride levels. Therefore, we evaluated NAFLD in our
model with the following five measures: liver to tibia ratios, plasma ALT and AST,
H&E, oil red O and hepatic triglycerides.
Mice fed high fat diet tended to have enlarged livers (Figure 3.4A) and
increased ALT, but not AST, levels compared to normal diet fed mice (Figure 3.4B
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Figure 3.2. Effects of high fat diet on body weight and composition in male
mice. This figure shows consumption of high fat diet for 24 weeks post weaning
(A) increased body weight gain over time and (B: representative DEXAscan photo
of a normal diet fed mouse; C: representative DEXAscan photo of a high fat diet
fed mouse) changed body composition, increasing (D) percent fat and (E) lean
tissue mass, but not (F) bone mineral content or (G) bone mineral density. Results
are reported as the mean ± SD for DEXAscan (n=6) and mean ± SEM (n=6) for
body weights. @, p < 0.05 compared to normal diet.
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Figure 3.3. Effects of high fat diet on glucose handling and plasma insulin in
male mice. This figure shows consumption of high fat diet for 24 weeks post
weaning (A) significantly decreased glucose tolerance (indicated by the area under
the curve (AUC) from IPGTT), (B) increased blood glucose levels and (C) tended
to increase plasma insulin levels. Taken together, these result are indicative of
insulin resistance. Results are reported as the mean ± SD (n=6). @, p < 0.05
compared to normal diet.
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Figure 3.4. Effects of high fat diet on liver injury and NAFLD in male mice.
This figure shows consumption of high fat diet for 24 weeks causes liver injury as
indicated by (A) enlarged livers (hepatomegaly determined by liver:tibia ratio), (B)
increased plasma ALT, but (C) not AST, and (D-H) steatosis. (D) Representative
photomicrographs of paraffin embedded liver tissue stained with hematoxylin &
eosin staining (H&E, 200x). (E) Steatosis was scored as percent of liver cells in 5,
10x fields per liver containing fat. (F) Representative photomicrographs of ORO
(neutral lipids, ×200) stained frozen liver sections. (G) Image analysis of ORO‐
positive staining was performed using Image J, and results are shown as
percentage of microscope field. (H) Biochemical quantification of hepatic
triglycerides. Results are reported as the mean ± SD (n=4-6). @, p < 0.05
compared to normal diet.
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and C), although not statistically significant. Histological analysis of liver tissue
revealed significant increases in steatosis and lipid deposition in mice fed high fat
diet compared to controls as seen in representative photomicrographs of H&E
(Figure 3.4D) and oil red O stained liver tissue (Figure 3.4F) as well as in the
quantification of the histology (Figure 3.4E and G). Additionally, biochemical
analysis of liver tissue showed high fat diet fed mice had greater hepatic
triglyceride levels compared to mice fed normal diet (Figure 3.4H). These NAFLD
markers combined with the changes in weight, percent fat, lean tissue mass, blood
glucose and plasma insulin show that our model of high fat diet-induced NAFLD
was successful.

Characterization of the cadmium exposure model
We also wanted to confirm that our cadmium exposure model was
successful. The liver is a major target organ of cadmium toxicity and accumulation
with a hepatic half-life of between 4-19 years (ATSDR, 1999; Hyder et al., 2013).
Metallothionein, a small, low molecular weight, cysteine rich protein, plays a major
role in protecting the body from cadmium toxicity and the expression of
metallothioneins generally increases with elevations in tissue cadmium levels
(Klaassen et al., 2009). There are 4 major mammalian isoforms of metallothionein,
of which MT-1 and MT-2 are highly expressed in the liver (Klaassen et al., 1999).
Therefore, we evaluated our cadmium exposure model by measuring cadmium
levels in liver tissue using ICP-MS and determining metallothionein protein and
mRNA (both MT-1 and MT-2) levels in the liver.
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As expected, cadmium accumulated in the liver in a concentrationdependent manner in both normal and high fat diet fed mice (Figure 3.5A). High
fat diet consumption did not influence cadmium accumulation in control or 5 ppm
exposed mice; however, high fat diet fed mice exposed to the lower concentration
of cadmium (0.5 ppm) had greater hepatic cadmium content compared to the
corresponding normal diet fed mice, although not statistically significant.
Additionally, in our model, mice were exposed to cadmium in their drinking
water, therefore we measured water consumption and calculated the average
administered cadmium intake (Figure 3.5B and C). Over the course of the study,
0.5 and 5 ppm cadmium exposed male mice drank an average of 5.15 ± 1.45 and
6.13 ± 1.45 mL of water per a day, respectively, compared to controls who drank
an average of 4.60 ± 0.55 mL of water per a day. Thus, treated mice drank similar
amounts of water compared to controls, independent of diet. The average daily
dose of cadmium in mice that drank water with 0.5 ppm cadmium was 2.58 ± 0.62
and 2.87 ± 0.71 μg in normal and high fat diet fed mice, respectively. In mice that
drank water with 5 ppm cadmium the average daily dose was significantly greater:
30.67 ± 7.27 (p = < 0.0001) and 24.53 ± 5.42 μg (p = < 0.0001) in normal and high
fat diet fed mice, respectively. Interestingly, in 5 ppm cadmium exposed male mice
fed high fat diet, cadmium intake was significantly decreased (p = 0.012) compared
to exposed, normal diet fed mice.
Overall, cadmium accumulated in our target organ, the liver. Therefore, we
next focused on determining the response of metallothionein in protection of the
liver against cadmium accumulation. In mice fed normal diet, exposure to 5 ppm
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Figure 3.5. Hepatic cadmium levels and weekly administered cadmium intake
in male mice. This figure shows cadmium accumulated in the liver in a
concentration-dependent manner, reflecting the average administered cadmium
intake delivered by drinking water. (A). Hepatic cadmium levels measured by ICPMS. (B) Average weekly administered cadmium intake delivered by drinking water
in normal diet fed mice. (C) Average weekly administered cadmium intake
delivered by drinking water in high fat diet fed mice. *, p < 0.05 compared to group
control; #, p < 0.05 compared to cadmium dose within diet group.
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Figure 3.6. Effects of whole life cadmium exposure and high fat diet on
metallothionein (MT) in male mice. Cadmium exposure alters MT. (A) Hepatic
mRNA expression of MT-1 and (B) MT-2. (C) Representative western blot for
hepatic MT in all exposure groups (NOTE: membrane cropped to remove loading
dye lane in the middle of the blot) and (D) corresponding densitometric analyses
shown as fold of control. (E) Representative western blot for hepatic MT in control
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mice and (F) corresponding densitometric analyses shown as fold of control. (G)
Representative western blot for hepatic MT in cadmium exposed mice and (H)
corresponding densitometric analyses shown as fold of control. GAPDH was used
as a loading control. Results are reported as the mean ± SD (n=2-6). *, p < 0.05
compared to group control; #, p < 0.05 compared to cadmium dose within diet
group; @, p < 0.05 compared to corresponding normal diet.
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cadmium resulted in a significant increase in mRNA levels of metallothionein
compared to controls, a result not observed in 0.5 ppm exposed mice (Figure 3.6A
and B). High fat diet alone did not alter hepatic mRNA levels of metallothionein;
however, there was a slight increase in metallothionein mRNA levels in high fat
diet fed mice exposed to 0.5 ppm cadmium. In contrast, in high fat diet fed mice
exposed to 5 ppm cadmium, metallothionein mRNA expression significantly
decreased compared to those fed normal diet.
In the liver, metallothionein protein levels showed a similar pattern to that of
metallothionein mRNA. Panel C (Figure 3.6) shows a representative western blot
containing samples (n=2) for each of the six experimental groups and Panel D
(Figure 3.6) shows quantification of the western blot; however, the protein levels
were so great in the cadmium exposed groups, that we were unable to detect
bands in any of the control mice and we were unable to clearly determine if there
were differences in metallothionein between cadmium exposure groups.
Therefore, we performed additional western blots to address these questions.
Panel E (Figure 3.6) is a representative western blot of control mice in which we
were able to observe faint bands in both normal and high fat diet fed animals. Panel
F (Figure 3.6) shows the quantification of the western blot. As was seen with
mRNA, high fat did not change hepatic metallothionein protein levels.
Panel G (Figure 3.6) shows a representative western blot of cadmium
exposed mice and Panel H (Figure 3.6) shows the quantification. For normal diet
animals, exposure to 5 ppm cadmium significantly increased metallothionein
protein levels compared to mice exposed to 0.5 ppm cadmium, which was
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consistent with the mRNA level results. By contrast, for high fat diet animals, 0.5
ppm cadmium increased metallothionein protein levels, but 5 ppm cadmium
tended to decrease levels such that high fat diet mice had lower metallothionein
levels compared to normal diet mice. These outcomes were consistent with the
mRNA data.
Thus, our data showed cadmium reaches the liver and metallothionein is
affected. Interestingly, the data begin to show different outcomes for 0.5 ppm and
5 ppm cadmium exposures. Exposure to 5 ppm cadmium increased both
metallothionein mRNA and protein levels in mice fed normal diet but did not do so
in high fat diet fed mice. In contrast, exposure to 0.5 ppm cadmium did not change
metallothionein mRNA or protein levels normal diet fed mice, but did tend to
increase these measures in high fat diet fed mice.

Impact of cadmium exposure on high fat diet-induced NAFLD
Once we confirmed we had a working model of high fat diet-induced NAFLD
and a successful cadmium exposure model we determined the impact of cadmium
exposure on high fat diet-induced NAFLD using the same nine measures
implemented in our model confirmation.

Body weight and composition
Normal-diet-fed mice exposed to 5 ppm cadmium had slightly reduced
weight gain compared to control and 0.5 ppm exposed mice, although not
statistically significant. (Figure 3.7A). High-fat-diet-fed mice exposed to 5 ppm
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Figure 3.7. Effects of whole life cadmium exposure and high fat diet on body
weight and composition in male mice. Whole life exposure to cadmium alters
body weight gain over time in high fat diet fed mice, but not body composition.
Body weight was measure once a week for 24 weeks starting at weaning, through
until sacrifice. Weekly body weight in (A) normal diet fed male mice and (B) high
fat diet fed mice. DEXAscan was performed one week prior to sacrifice for control
and 5 ppm cadmium exposed mice to assess body composition changes. (C)
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Percent fat, (D) lean tissue mass, (E) bone mineral density and (F) bone mineral
content. Results are reported as the mean ± SD for DEXAscan (n=3-6) and mean
± SEM (n=4-6) for body weights. @, p < 0.05 compared to corresponding normal
diet.
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cadmium gained significantly more weight compared to their corresponding high
fat diet-fed controls (p = <0.001), while high-fat-diet-fed mice exposed to 0.5 ppm
cadmium had reduced weight gain compared to their corresponding controls (p =
<0.001) (Figure 3.7B). These data suggest 5 ppm cadmium exacerbates high fat
diet-induced weight gain while 0.5 ppm cadmium reduces weight gain resulting
from eating a high fat diet. DEXAscans on control and 5 ppm cadmium exposed
mice, did not indicate any further changes in body composition (i.e. % fat, lean
tissue mass, bone mineral density or bone mineral content) as a result of cadmium
exposure (Figure 3.7C-F). Mice exposed to 0.5 ppm cadmium were excluded from
DEXAscans due to budgetary limitations.

IPGTT and plasma insulin
In normal diet fed mice, cadmium exposure did not significantly alter
glucose clearance (Figure 3.8A and C). Similarly, 5 ppm cadmium exposure did
not significantly impact high-fat-diet-induced impairment of glucose clearance
(Figure 3.8B and C). However, mice exposed to 0.5 ppm cadmium actually showed
improved glucose clearance and reduced plasma insulin levels similar to those
observed in normal diet-fed animals (Figure 3.8D).
Hepatic injury and NAFLD
High fat diet fed mice exposed to 5 ppm cadmium had significantly larger
livers compared to those fed normal diet and compared to high fat diet-fed controls,
showing exposure to 5 ppm significantly exacerbated high fat diet-induced
hepatomegaly (Figure 3.9A). Interestingly, independent of diet, exposure to 5 ppm
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Figure 3.8. Effects of whole life exposure to cadmium and high fat diet on
glucose handling and plasma insulin in male mice. Whole life exposure to
cadmium alters glucose clearance and plasma insulin in high fat diet fed male
mice. Blood glucose levels in (A) normal diet fed mice and (B) high fat diet fed mice
after IPGTT, performed one week prior to sacrifice. (C) Integrated area under the
curve (AUC) showing quantitative changes in blood glucose levels after glucose
challenge. (D) Insulin levels in plasma at time of sacrifice. Results are reported as
the mean ± SD (n=4-6). *, p < 0.05 compared to group control; #, p < 0.05
compared to cadmium dose within diet group; @, p < 0.05 compared to
corresponding normal diet.
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cadmium caused liver injury as indicated by increased ALT and AST levels,
suggesting exposure to cadmium alone inflicts damage to the liver (Figure 3.9B
and C).
Liver damage was not reflected in normal diet-fed mice according to liver
morphology (Figure 3.10A and C) and lipid deposition (Figure 3.10B and D);
however cadmium exposure did significantly impact these measures in high fat
diet-fed mice. More specifically, 5 ppm cadmium exacerbated high fat diet-induced
steatosis and biochemical analysis of hepatic triglyceride content confirmed these
results (Figure 3.11A). However, total hepatic cholesterol levels remained
unchanged (Figure 3.11B).
Similar to 5 ppm cadmium, exposure to 0.5 ppm cadmium did not overtly
impact liver morphology or lipid deposition in normal diet fed mice. However, the
outcomes in high fat diet mice after 0.5 ppm cadmium continued to be very different
from 5 ppm cadmium. In fact, 0.5 ppm cadmium reduced the size of the high fat
diet-enlarged livers, down to levels seen in normal diet fed mice and did not result
in liver injury (Figures 3.9A-C). Consistent with these observations, 0.5 ppm
cadmium reduced the pathology to levels seen in normal diet fed mice (Figure 3.10
A-D). Taken together these data indicate exposure to 5 ppm cadmium exacerbates
high fat diet-induced NAFLD while exposure to 0.5 ppm cadmium attenuates the
diet-induced hepatic pathology, possibly through altering hepatic lipid synthesis.
We also delved deeper into a possible underlying molecular mechanism.
Dysregulation of hepatic lipid homeostasis is a hallmark of NAFLD (Moslehi and
Hamidi-Zad, 2018). The master regulator of hepatic lipid synthesis, sterol
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Figure 3.9. Effects of whole life cadmium exposure and high fat diet on liver
injury in male mice. This figure shows cadmium exposure changes liver size in
high fat diet fed mice and exposure to 5 ppm cadmium increases liver
transaminases, independent of diet. (A) Ratio of liver weight in grams to tibia length
in

millimeters,

a

measure

of

hepatomegaly.

(B)

Plasma

aspartate

aminotransferase (AST) and (C) plasma alanine aminotransferase (ALT) activity.
Results are reported as the mean ± SD (n=4-6). *, p < 0.05 compared to group
control; #, p < 0.05 compared to cadmium dose within diet group; @, p < 0.05
compared to corresponding normal diet.

56

Figure 3.10. Effects of whole life cadmium exposure and high fat diet on
NAFLD in male mice. This figure shows exposure to 5 ppm cadmium exacerbated
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high fat diet-induced steatosis while exposure to 0.5 ppm cadmium rescues high
fat diet-induced steatosis. (A) Representative photomicrographs of paraffin
embedded liver tissue stained with hematoxylin & eosin staining (H&E, 200x). (C)
Steatosis was scored as percent of liver cells in 5, 10x fields per liver containing
fat. (B) Representative photomicrographs of Oil Red O (neutral lipids, ×200)
stained frozen liver sections. (D) Image analysis of ORO‐positive staining was
performed using Image J, and results are shown as percentage of microscope
field. Results are reported as the mean ± SD (n=4-6). *, p < 0.05 compared to
group control; #, p < 0.05 compared to cadmium dose within diet group; @, p <
0.05 compared to corresponding normal diet.
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Figure 3.11. Effects of whole life cadmium exposure and high fat diet on
biochemical measures of NAFLD in male mice. This figure shows cadmium
exposure alters hepatic triglycerides in high fat diet fed mice, but not total
cholesterol. (A) Hepatic triglyceride levels. (B) Total hepatic cholesterol levels.
Results are reported as the mean ± SD (n=4-6). *, p < 0.05 compared to group
control; #, p < 0.05 compared to cadmium dose within diet group; @, p < 0.05
compared to corresponding normal diet.
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regulatory element binding protein-1 (SREBP-1), which is responsible for the
transcription of rate limiting lipogenic enzymes including fatty acid synthase
(FASN) and stearoyl-CoA desaturase-1 (SCD-1) (Moslehi and Hamidi-Zad, 2018;
Pei et al., 2020) contributes to the pathogenesis of NAFLD. Therefore, we
assessed the levels of SREBP-1 in the liver.
SREBP-1 is first synthesized as inactive precursor tethered to the
endoplasmic reticulum membrane and requires post-translational modification (i.e
proteolytic cleavage) to produce its mature, transcriptionally active form (Ferre and
Foufelle, 2007; Xiaoping and Fajun, 2012; Moslehi and Hamidi-Zad, 2018).
Therefore we measured the cleaved, mature form of SREBP-1 (pro-SREBP-1) in
addition to the full-length SREBP-1 (pro-SREBP-1). In control mice, consumption
of high fat diet did not change mRNA or proteins levels of hepatic SREBP-1 (Figure
3.12A-E); however there was a decrease in the mRNA of two of SREBP-1’s
downstream targets, Fasn and Scd-1 (Figure 3.12F and G). In mice fed normal
diet, cadmium exposure also did not significantly alter Srebf-1 mRNA or SREBP-1
protein levels in the liver (Figure 3.12A-E)
For high fat diet mice, although Srebf-1 mRNA levels were not significantly
changed in mice exposed to 5 ppm cadmium, SREBP-1 protein levels were
significantly decreased compared to both high fat diet controls and 5 ppm cadmium
exposed mice fed normal diet (Figure 3.12A-E). This decrease in SREBP-1 protein
levels was reflected in the mRNA levels of its downstream targets, Fasn and Scd1 (Figure 3.12F and G).
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Figure 3.12. Effects of whole life cadmium exposure and high fat diet on
SREBP-1 mediated lipogenesis. This figure shows cadmium-associated
influences on high fat diet-induced NAFLD are not through SREBP-1 mediated
lipogenesis. (A) Srebf-1 mRNA. (B) Representative western blot for hepatic
SREBP-1 in all exposure groups. GAPDH was used as a loading control.
Corresponding densitometric analyses shown as fold of control for (C) pro-SREBP1 (uncleaved; inactive), (D) mature (m)-SREBP-1 (cleaved; active) and (E) m/pro
SREBP-1 ratio. mRNA levels for SREBP-1 downstream targets (F) Fasn and (G)
Scd-1. Results are reported as the mean ± SD (n=4-6). *, p < 0.05 compared to
group control; #, p < 0.05 compared to cadmium dose within diet group; @, p <
0.05 compared to corresponding normal diet.
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Interestingly, in mice fed high fat diet exposure to 0.5 ppm cadmium
significantly increased Srebf-1 mRNA levels compared to high fat diet fed controls,
which was reflected in the protein levels of SREBP-1 (Figure 3.12A-E). However,
the observed 0.5 ppm cadmium-induced increases in SREBP-1 did not translate
into increased Fasn or Scd-1 mRNA, both of which were expressed at levels
similar to that of high fat diet fed controls (Figure 3.12F and G).

Summary
In this aim we first showed feeding male mice a high fat diet for 24 weeks
post weaning caused weight gain over time, increased percent fat and lean tissue
mass in the body and induced hyperglycemia while also increasing plasma insulin,
indicative of insulin resistance. Furthermore, high fat diet caused liver injury,
indicated by increased liver weight to tibia ratios and plasma ALT levels and
significantly increased steatosis supported by oil red O and total hepatic
triglyceride measurements. Taken together, we show that our model of high fat
diet-induced NAFLD was successful.
We next showed our cadmium exposure model was successful. Cadmium
accumulated in the liver in a concentration-dependent manner in mice exposed to
cadmium. In mice exposed to the high concentration of cadmium (5 ppm), the
cadmium accumulation was independent of diet. However, in mice exposed to the
lower concentration of cadmium (0.5 ppm), high fat diet feeding resulted in greater
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cadmium accumulation compared to those fed normal diet. Taken together, we
show that our model of high fat diet-induced NAFLD was successful.
When we tested for cadmium effects on the hepatic expression of
metallothionein, a key factor in cadmium detoxification, we found differing
outcomes depending on the exposure. Hepatic metallothionein expression was
assessed at both mRNA and protein levels. In high fat diet fed mice, 5 ppm
cadmium

exposure

dramatically

lowered

metallothionein

response

and

exacerbated high fat diet-induced NAFLD. In contrast, in high fat diet fed mice, 0.5
ppm cadmium exposure increased the metallothionein response and rescued high
fat diet-induced NAFLD.

Aim 2. Show zinc supplementation protects against cadmium-enhanced,
high fat diet-induced NAFLD
Background
Zinc is an essential trace metal required for a variety of biological functions.
More than 2,000 transcription factors and 300 enzymes require zinc for structural
maintenance and appropriate functionality, indicating zinc is a key factor in
numerous metabolic processes including glucose and lipid metabolism (Miao et
al., 2013; Livingstone, 2015). Dysregulation of zinc homeostasis is associated with
various metabolic disease pathologies (Seo et al., 2014). For example, zinc
deficiency is common in obese, diabetic and NAFLD patients (Miao et al., 2013;
Fukunaka and Fujitani, 2018; Shidfar et al., 2018) while zinc supplementation can
reduce obesity, blood glucose levels and hepatic lipid deposition (Mahawar et al.,
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2017; Thoen et al., 2019; Qi et al., 2020). Our laboratory showed zinc protects
against diabetes-induced damage to multiple organs, including the liver and
kidney, by increasing sensitivity to insulin and decreasing inflammation and
oxidative stress (Li et al., 2014; Liang et al., 2015). In addition, we showed cardiac
hypertrophy associated with high fat diet-induced obesity is exacerbated by zinc
deficiency and rescued by zinc supplementation (Wang et al., 2016; Wang et al.,
2017); however, the mechanism by which zinc offers protection against metabolic
diseases is not completely understood.
The interactions between zinc and cadmium in the human body is
considered to be one of the most well recognized and studied metal-metal
interactions. Similarities between cadmium and zinc, such as they both tend to
form tetrahedral complexes and are both group 2B transition metals that tend to
form 2+ charges, result in them having similar interactions with the human body
(Peraza et al., 1998). Therefore, it is not surprising that one of the main
mechanisms of cadmium toxicity involves cadmium-induced dysregulation of zinc
metabolism and functionality; hence, cadmium is labeled a zinc antimetabolite
(Cotzias and Papavasiliou, 1964; Peraza et al., 1998). Cadmium displaces zinc in
numerous metallo-enzymes and zinc finger proteins, resulting in activity reduction
of zinc containing enzymes and interference with essential metal homeostasis
(Martelli et al., 2006; Namdarghanbari et al., 2014); thus, some symptoms of
cadmium resemble those seen with zinc deficiency (Peraza et al., 1998).
Epidemiologically, increased intake of dietary zinc is associated with lower
cadmium burden (Vance and Chun, 2015). Experimentally, zinc supplementation
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has been shown to alleviate symptoms of cadmium toxicity since the 1960’s when
Supplee (1961) showed cadmium toxicity in turkey poults (decrease growth rate
and feather abnormalities) could be reversed with zinc supplements. Furthermore,
zinc supplementation can counteract cadmium-induced inflammation, cell cycle
dysregulation, and cadmium accumulation (Zhai et al., 2015; Zhang et al., 2014;
Bonaventura et al., 2017). However, whether zinc supplementation can protect
against cadmium-enhanced, high fat diet-induced liver disease is unknown, and
its ability to rescue high fat diet-induced NAFLD, in general, is understudied.
In Aim 1, we showed our high fat diet model successfully induced NAFLD,
our cadmium exposure model was effective, resulting in a concentration
dependent increase in hepatic cadmium levels, and exposure to 5 ppm cadmium
in drinking water, starting in utero and continuing through adulthood, exacerbated
high fat diet-induced liver disease. Therefore, following the same exposure
paradigm used in Aim 1, we investigated the ability of zinc supplementation (90
mg zinc/4057 kcal) to protect against cadmium-exacerbated, high fat diet-induced
NAFLD (Figure 3.13)

Findings
Impact of zinc supplementation on high fat diet-induced NAFLD
Our first objective was to determine the impact of zinc supplementation on
our high fat diet model using the same 9 measures used in Aim 1, first
characterizing the model at the whole mouse level followed by investigation at the
hepatic tissue level. Zinc supplementation did not influence weight gain over time
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Figure 3.13. Model of whole life exposure of male mice to cadmium and high
fat diet supplemented with zinc. Adult male and female C57BL/6J mice on
defined diets were exposed to control drinking water, or water containing 5 ppm
cadmium for 14 weeks before being established into breeding pairs. Pregnant
dams and offspring were continuously exposed and continued on the same
drinking water regime as their parents after weaning. At weaning, male offspring
were also fed either a normal or high-fat diet (ND or HFD, respectively) containing
30 or 90 mg zinc/4057 kcal, representing normal zinc (ZN) and zinc supplemented
(ZS) diet, respectively, for 24 weeks. The same paradigm will be used in Aim 3
with the modulation of zinc in the diet. One week prior to sacrifice, IPGTT tests
were performed and body composition determine by DEXAscan (DS). IPGTT =
intra-peritoneal glucose tolerance test, wks = weeks.
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Figure 3.14. Effects of zinc supplementation and high fat diet on body weight
and composition in male mice. This figure shows zinc supplementation did not
alter body weight or body composition in male mice after 24 weeks of diet, post
weaning. Weekly body weight in (A) normal diet fed mice and (B) high fat diet fed
mice. DEXAscan was performed one week prior to sacrifice for control and 5 ppm
cadmium exposed mice to assess body composition changes. (C) Percent fat, (D)
lean tissue mass, (E) bone mineral density and (F) bone mineral content. Results
are reported as the mean ± SD (n=2-6) for DEXAscan and mean ± SEM (n=2-6)
for body weights. @, p < 0.05 compared to normal diet.
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in normal or high fat diet-fed mice (Figure 3.14A and B) nor did it alter DEXAscan
measured parameters of body composition: percent fat, lean tissue mass, bone
mineral density or bone mineral content (Figure 3.14C-F). Therefore this finding
indicates that in our model, zinc supplementation did not attenuate high fat dietinduced weight gain or fat mass. Following a glucose challenge, zinc
supplementation did not alter glucose uptake in normal diet-fed mice (Figure 3.15A
and C); however, in mice consuming high fat diet, zinc supplementation tended to
decrease blood sugar levels (Figure 3.15B and C). These results were also
reflected in the plasma insulin levels (Figure 3.15D). Zinc supplementation tended
to reduce hepatic injury resulting from high fat diet as measured by liver weight to
tibia length ratios (Figure 3.16A) and plasma ALT (Figure 3.16B), but not AST
(Figure 3.16C). Histological analysis of the liver by H&E (Figure 3.17A and B) and
oil red O staining (Figure 3.17C and D) showed zinc supplementation decreased
steatosis and reduced staining of neutral lipids. In addition, hepatic triglycerides
were reduced as a result of zinc supplementation (Figure 3.17E). These results
indicate zinc supplementation tended to rescue high fat diet-induced liver damage
without influencing weight gain or body composition.

Impact of zinc supplementation on general cadmium measures
Next, we investigated the impact of zinc supplementation on our cadmium
exposure model. We first measured hepatic zinc levels in order to determine if the
addition of zinc to the diet translated to increased zinc in the liver. In mice fed
normal diet, zinc supplementation did not change hepatic zinc levels in control or
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Figure 3.15. Effects of zinc supplementation and high fat diet on glucose
handling and plasma insulin in male mice. This figure shows zinc
supplementation tended to decrease high fat diet-associated glucose intolerance
and plasma insulin levels, although statistical significance was observed. A) Blood
glucose levels in normal diet-fed mice and (B) high fat diet-fed mice after IPGTT,
performed one week prior to sacrifice. (C) Integrated area under the curve (AUC)
showing quantitative changes in blood glucose levels after glucose challenge. (D)
Insulin levels in plasma at time of sacrifice. Results are reported as the mean ± SD
(n=2-6). @, p < 0.05 compared to normal diet.
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Figure 3.16. Effects of zinc supplementation and high fat diet on liver injury
in male mice. This figure shows zinc supplementation tended to decrease liver
injury although no statistical significance was observed. (A) Ratio of liver weight in
grams to tibia length in millimeters, a measure of hepatomegaly. (B) Plasma
aspartate aminotransferase (AST) and (C) plasma alanine aminotransferase (ALT)
activity. Results are reported as the mean ± SD (n=2-6).
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Figure 3.17. Effects of zinc supplementation and high fat diet on NAFLD in
male mice. This figure shows zinc supplementation tended to decrease high fat
diet-induced NAFLD, although no statistical significance was observed. (A)
Representative photomicrographs of paraffin embedded liver tissue stained with
hematoxylin & eosin staining (H&E, 200x). (C) Steatosis was scored as percent of
liver cells in 5, 10x fields per liver containing fat. (B) Representative
photomicrographs of Oil Red O (neutral lipids, ×200) stained frozen liver sections.
(D) Image analysis of ORO‐positive staining was performed using Image J, and
results are shown as percentage of microscope field. (E) Biochemical
quantification of hepatic triglycerides. Results are reported as the mean ± SD (n=26). @, p < 0.05 compared to corresponding normal diet.
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Figure 3.18. Hepatic cadmium and zinc levels and weekly administered
cadmium intake in zinc supplemented male mice. This figure shows zinc
supplementation increased zinc and cadmium accumulation in high fat diet fed
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male mice, reflecting the average administered cadmium intake delivered by
drinking water. (A) Hepatic zinc levels measured by ICP-MS. (B) Hepatic cadmium
levels measured by ICP-MS. (C) Average weekly administered cadmium intake
delivered by drinking water in zinc supplemented, normal diet fed mice. (D)
Average weekly administered cadmium intake delivered by drinking water in in zinc
supplemented, high fat diet fed mice. *, p < 0.05 compared to group control; #, p <
0.05 compared to cadmium dose within diet group.
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cadmium exposed mice (Figure 3.18A). In contrast, although not statistically
significant, in high fat diet-fed mice, mean hepatic zinc levels increased
approximately 30% in both control and cadmium exposed animals, respectively,
as a result of dietary zinc supplementation. Dietary zinc supplementation did not
change cadmium levels in the liver of neither control nor 5 ppm cadmium exposed
mice fed normal diet (Figure 3.18B). In mice fed high fat diet, zinc supplementation
slightly increased cadmium levels in control mice whereas in mice exposed to 5
ppm cadmium, mean hepatic cadmium levels (cadmium = 1584 ng/g) were more
than double those of mice with a normal amount of zinc in their diet (cadmium =
705 ng/g), suggesting increased intake of dietary zinc provides a mechanism for
greater cadmium accumulation in the liver in addition to greater hepatic zinc levels.
Mice were exposed to cadmium in their drinking water, thus we measured
water consumption and calculated the average administered cadmium intake to
determine zinc supplementation altered cadmium intake (Figure 3.18B and C).
Over the course of the study, 5 ppm cadmium exposed mice fed zinc
supplemented normal or high fat diet drank an average of 5.24 ± 1.41 and 6.62 ±
1.23 mL of water per a day in normal and high, respectively and these results were
not significantly different from the corresponding mice fed diets with normal zinc.
Therefore, cadmium exposed mice drank similar amounts of water independent of
dietary zinc or fat levels. The average daily dose of cadmium in zinc supplemented
mice that drank water with 5 ppm cadmium was 26.18 ± 7.07 and 33.08 ± 6.15 μg
in normal and high fat diet fed mice, respectively. Interestingly, in high fat diet fed
mice the average daily dose of cadmium in 5 ppm cadmium exposed mice
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supplemented with zinc was significant greater than in mice with normal zinc
(p<0.0001). Overall, zinc supplementation did not change water consumption, but
did increase cadmium uptake in high fat diet fed animals.
In addition to being one of the principal detoxification mechanisms against
cadmium toxicity, metallothionein is crucial in the physiological maintenance of
zinc homeostasis (Funk et al., 1987). Synthesis of metallothionein is induced by
the presence of both zinc and cadmium. Therefore, one of the reasons for the
protective effects of zinc supplementation against cadmium toxicity is through the
production of metallothionein (Stonard and Webb, 1976; Peraza et al., 1998). We
investigated the impact of zinc supplementation on hepatic metallothionein levels
in our model. Zinc supplementation significantly reduced the cadmium-induced
increases in mRNA levels of metallothionein in normal diet fed mice found in Aim
1 (Figure 3.19A and B). In high fat diet fed mice, zinc supplementation significantly
increased metallothionein mRNA in controls, but not in cadmium exposed mice
(Figure 3.19A and B). Overall, the mRNA levels of the two isoforms of
metallothionein (Mt-1 and Mt-2) correlated at both the exposure group and
individual mouse level. However, the mRNA levels of Mt-2 were approximately 2
times greater than Mt-1 levels in both high fat diet fed control animals
supplemented with zinc and in normal diet fed animals exposed to 5 ppm cadmium.
We also assessed hepatic metallothionein protein levels. We found in mice
supplemented with zinc, high fat diet changed metallothionein protein levels in
control animals, but not in cadmium exposed animals compared to mice
consuming a normal diet (Figure 3.19C and D). We also found in high fat diet fed
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Figure 3.19. Effects of zinc supplementation, cadmium exposure and high fat
diet on metallothionein (MT) in male mice. (A) Hepatic mRNA expression of MT1 and (B) MT-2. (C) Representative western blot for hepatic MT in zinc
supplemented mice and (D) corresponding densitometric analyses shown as fold
of control. (E) Representative western blot for hepatic MT in high fat diet fed mice
and (F) corresponding densitometric analyses shown as fold of control. GAPDH
was used as a loading control. Results are reported as the mean ± SD (n=2-6). *,
p < 0.05 compared to group control; #, p < 0.05 compared to cadmium dose within
diet group; @, p < 0.05 compared to corresponding normal diet.
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mice zinc supplementation increased metallothionein protein levels in both control
and cadmium exposed mice compared to mice consuming a high fat diet with
normal zinc (Figure 3.19E and F). At both an individual mouse and exposure group
level metallothionein mRNA levels correlate with protein levels. Thus, overall, as
evidenced by both mRNA and protein levels, zinc supplementation in high fat diet
fed mice increased metallothionein levels in both control and cadmium exposed
mice; therefore indicating a possible mechanism by which zinc supplementation
may attenuate cadmium-exacerbated, high fat diet-induced NAFLD.

Impact of zinc supplementation on cadmium-exacerbated, high fat dietinduced NAFLD
In Aim 1, we found exposure to 5 ppm cadmium did not influence body
weight gain in normal diet-fed mice and we found that zinc supplementation did
not change this result (Figure 3.20A). In contrast, we reported exposure to 5 ppm
cadmium enhanced high fat diet-induced weight gain and found zinc
supplementation significantly attenuated this weight gain to levels below those
found in high fat diet control mice (p = 0.001, Figure 3.20B). Due to budgetary
restraints, DEXAscan was not performed on normal diet fed, zinc supplemented
mice exposed to 5 ppm cadmium. However, our hypothesis is centered on zinc
supplementation rescuing high fat diet-induced effects; thus these data are useful,
showing zinc supplementation significantly reduced the percentage of fat in 5 ppm
cadmium exposed mice fed high fat diet (Figure 3.20C) although lean tissue, bone
mineral density and bone mineral content were unchanged (Figure 3.20D-F).
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Figure 3.20. Effects of zinc supplementation on cadmium-exacerbated, high
fat diet-induced weight gain and body composition in male mice. Zinc
supplementation reduced body weight gain in high fat diet fed mice exposed to 5
ppm cadmium as well as percent fat. Body weight was measured once a week for
24 weeks starting at weaning, through until sacrifice. Weekly body weight in (A)
normal diet fed male mice and (B) high fat diet fed mice with or without zinc
supplementation. DEXAscan was performed one week prior to sacrifice for control
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and 5 ppm cadmium exposed mice to assess body composition changes. (C)
Percent fat, (D) lean tissue mass, (E) bone mineral density and (F) bone mineral
content. Results are reported as the mean ± SD for DEXAscan (n=2-6) and mean
± SEM (n=2-6) for body weights. #, p < 0.05 compared to corresponding normal
zinc diet; @, p < 0.05 compared to corresponding normal diet.
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Figure 3.21. Effects of zinc supplementation on cadmium and high fat dietaltered glucose handling and plasma insulin in male mice. Zinc
supplementation tended to reduce glucose intolerance in high fat diet fed mice,
independent of cadmium exposure. Blood glucose levels in (A) normal diet fed
and (B) high fat diet fed mice after IPGTT, performed one week prior to sacrifice.
(C) Integrated area under the curve (AUC) showing quantitative changes in blood
glucose levels after glucose challenge. (D) Insulin levels in plasma at time of
sacrifice. Results are reported as the mean ± SD (n=2-6). @, p < 0.05 compared
to corresponding normal diet.
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In addition, similar to what was observed in high fat diet-fed control animals,
zinc supplementation tended to decrease blood sugar levels in the 5 ppm cadmium
exposed animals fed high fat diet (Figure 3.21A-C). However, the ability of
additional zinc to attenuate these cadmium-exacerbated, high-fat-diet-induced
outcomes was not reflected in the plasma insulin levels (Figure 3.21D). Taken
together, these data suggest zinc supplementation can attenuate the enhanced
high fat diet-induced outcomes, at least at the whole animal level, resulting from
cadmium exposure.
Therefore, the next step was to determine if zinc supplementation could
rescue the liver injury and worsened steatosis observed in our model as a result
of cadmium exposure in combination with high fat diet. Indeed, liver injury was
significantly reduced in high-fat-diet-fed, cadmium-exposed mice when given
additional zinc in their diet (Figure 3.22A-C). Furthermore, zinc supplementation
significantly reduced both steatosis (Figure 3.23 A and C) and neutral lipids (Figure
3.23B and D) in cadmium exposed animals fed high fat diet as well as significantly
decreased hepatic triglycerides (Figure 3.24) compared to the corresponding mice
with normal zinc levels in their diet.
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Figure 3.22. Zinc supplementation recues cadmium-exacerbated, high fat
diet-induced liver injury in male mice. (A) Ratio of liver weight in grams to tibia
length in millimeters, a measure of hepatomegaly. (B) Plasma aspartate
aminotransferase (AST) and (C) plasma alanine aminotransferase (ALT) activity.
Results are reported as the mean ± SD (n=2-6). *, p < 0.05 compared to group
control; #, p < 0.05 compared to corresponding normal zinc diet; @, p < 0.05
compared to corresponding normal diet.
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Figure 3.23. Zinc Supplementation recues cadmium-exacerbated, high fat
diet-induced NAFLD in male mice. (A) Representative photomicrographs of
paraffin embedded liver tissue stained with hematoxylin & eosin staining (H&E,
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200x). (C) Steatosis was scored as percent of liver cells in 5, 10x fields per liver
containing fat. (B) Representative photomicrographs of Oil Red O (neutral lipids,
×200) stained frozen liver sections. (D) Image analysis of ORO‐positive staining
was performed using Image J, and results are shown as percentage of microscope
field. Results are reported as the mean ± SD (n=2-6). *, p < 0.05 compared to
group control; #, p < 0.05 compared to corresponding normal zinc diet; @, p < 0.05
compared to corresponding normal diet.
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Figure 3.24. Zinc supplementation recues cadmium-exacerbated, high fat
diet-induce hepatic triglycerides in male mice. Results are reported as the
mean ± SD (n=2-6). #, p < 0.05 compared to corresponding normal zinc diet; @, p
< 0.05 compared to corresponding normal diet.
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Summary
The results of this Aim show zinc supplementation did impact normal dietfed control mice. However, in high fat diet-fed mice zinc supplementation could
marginally attenuate NAFLD in control animals as indicated by trends of
decreasing hyperglycemia, hepatomegaly, ALT, steatosis, lipid deposition and
hepatic triglycerides (Table 3.1).

Table 3.1. Summary of the effects of zinc supplementation in control mice.

By contrast, zinc supplementation had a much stronger effect on cadmium
exposed animals. Zinc supplementation increased hepatic zinc, cadmium and
metallothionein levels in high fat diet-fed mice, but not normal diet fed mice
(Figures 3.18 and 3.19). Supplementation also attenuated cadmium exacerbated,
high fat diet-induced NAFLD by significantly decreasing hepatomegaly, plasma
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ALT levels, steatosis, lipid deposition and hepatic triglycerides (Table 3.2). Overall,
these data implicate the use of zinc supplementation as a possible therapeutic for
NAFLD, which may in part act by targeting metallothionein.

Table 3.2. Summary of zinc supplementation effects in cadmium exposed,
high fat diet fed mice.

Aim 3. Determine the role of sex in cadmium-enhanced, high fat diet-induced
NAFLD
Background
Traditionally, the importance of the basic biological differences between
males and females has been overlooked in biomedical science (Arnold, 2010;
Morrow, 2015). However, more recently it has become abundantly clear that the
basic physiological differences between males and females contributes not only to
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disease susceptibility and progression, but also implies there are sex-specific
factors that provide disease protection (Arnold, 2010). Starting in 1990 with the
establishment of Office of Research on Women’s Health (ORWH), the U.S.
National Institutes of Health (NIH) has recognized the essentiality of evaluating the
effects of sex differences in understanding diseases and for developing more
targeted therapies (Clayton and Collins, 2014). Indeed, since 2014 when NIH
announced policies requiring grant applicants to assess sex differences in
preclinical trials (i.e. in cells and animals) unless inclusion of a single sex is
warranted, the number of publications on sex differences has increased (Clayton
and Collins, 2014; Lonardo et al., 2019), providing valuable insight for research
scientists and clinicians alike.
NAFLD is one of many diseases that are now being considered “sexually
dimorphic”. Epidemiologically, NAFLD occurs more often in men than in women,
and with greater severity (Lazo et al., 2013; Long et al., 2018; Lonardo et al., 2019).
In animal models, these differences are generally recapitulated with male mice
presenting with more severe steatosis, steatohepatitis, inflammation and tumors in
their liver (Kirsch et al., 2013; Ganz et al., 2014; Northeim et al., 2017). Obesity,
one of the greatest risk factors for NAFLD, is also a sexually dimorphic disease.
For example, in both humans and rodents, females are protected from the adverse
consequences of obesity and its associated metabolic pathologies (Pettersson et
al., 2012; Palmer and Clegg, 2015). There are however contradictory studies
showing female mice are more susceptible to NAFLD despite male mice gaining
more absolute weight (Spruss et al., 2012).
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Interestingly, independent of obesity, NAFLD occurs in approximately 20%
of the lean population, indicating the influence of other factors, such as
environmental exposures (Younossi et al., 2018). Taken together, it is clear that
males are generally more susceptible to NAFLD than females; however, these
studies neither take into account the influence of environmental factors, such as
exposures to heavy metals, in causing sex-dependent differences in disease
outcome nor do they incorporate the interaction of environmental factors and diet.
Exposure to the non-essential heavy metal cadmium is one possible
environmental factor that could interact with biological forces to influence the
sexual dimorphism of disease outcome. Overall, the health related effects of
cadmium are reported to be more common among women (Wang et al., 2003;
Vahter et al., 2007; Akesson et al., 2005); however, these reports are generally
from occupational exposures and without consideration of low-dose environmental
exposures. In addition, these reports do not take into account the effects of early
life exposure to cadmium even though there is clear evidence for sex-specific
associations between maternal cadmium levels and adverse birth outcomes
(Young and Cai, 2020). Further, few studies have investigated the impact of early
life-exposure to cadmium on the development of diseases later in the life of
females.
Therefore, using the same experimental exposure paradigm presented in
Aim 1, we determined the impact of whole life (in utero through adult-hood)
exposure to low concentrations of cadmium on the development of high fat dietinduced NAFLD in female mice (Figure 3.25).
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Figure 3.25. Model of whole life exposure of female mice to cadmium and
high fat diet. (A) Adult male and female C57BL/6J mice on defined diets were
exposed to control drinking water, or water containing 0.5 or 5 ppm cadmium for
14 weeks before being established into breeding pairs. Pregnant dams and female
offspring were continuously exposed and continued on the same drinking water
regime as their parents after weaning. At weaning, female offspring were also fed
either a normal or high-fat diet (ND or HFD, respectively) for 24 weeks. (B) One
week prior to sacrifice, IPGTT tests were performed and body composition
determine by DEXAscan (DS). IPGTT = intra-peritoneal glucose tolerance test,
wks = weeks.
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Findings
Characterization of the high fat diet model used to induce NAFLD
Our first objective was to confirm our high fat diet model was successful in
female mice. Similar to Aim 1, we began evaluating our model by using four
measures: Body weight, DEXAscan, intraperitoneal glucose tolerance tests
(IPGTT) and plasms insulin. Female mice fed high fat diet gained significantly more
bodyweight over time compared to normal diet fed mice (p < 0.001) (Figure 3.26AC). Although not statistically significant, high fat diet feeding trended to increase
percent fat (p = 0.0533) (Figure 3.26D), as measured by DEXAscan but did not
alter lean tissue mass, bone mineral density or bone mineral content (Figure
3.26E, F and G). Blood glucose levels were significantly increased in high fat dietfed mice (Figure 3.27A and B); however, plasma insulin levels did not change
(Figure 3.27C).
Next we determined if our high fat diet induced NAFLD in female mice with
five measures: liver weight to tibia length ratios, plasma ALT and AST, H&E, oil
red O and hepatic triglycerides. High fat diet consumption did not increase liver
size (liver weight: tibia length ratios, Figure 3.28A) or plasma transaminases (ALT
and AST, Figures 3.28B and C). Histological analysis by H&E suggested
consumption of high fat diet tended to increase steatosis, however, these results
were not statistically significant (p = 0.0537) (H&E, Figure 3.28D and E). However,
high fat diet consumption did not alter oil red O-staining for neutral lipids in the
liver. (Figure 3.28F and G). In contrast, biochemical analysis indicated significant
increases in triglycerides in high fat diet-fed females compared to female mice fed
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Figure 3.26. Effects of high fat diet on body weight and composition in female
mice. This figure shows consumption of high fat diet for 24 weeks post weaning
(A) increased body weight gain over time and (B: representative DEXAscan photo
of a normal diet fed mouse; C: representative DEXAscan photo of a high fat diet
fed mouse) changed body composition, increasing (D) percent fat and (E) lean
tissue mass (although not statistically significant) but not (F) bone mineral content
or (G) bone mineral density. Results are reported as the mean ± SD (n=3) for
DEXAscan and mean ± SEM (n=7-8) for body weight. @, p < 0.05 compared to
normal diet.
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Figure 3.27. Effects of high fat diet on glucose handling and plasma insulin
in female mice. This figure shows consumption of high fat diet for 24 weeks post
weaning (A) significantly decreased glucose tolerance (indicated by the area under
the curve (AUC) from IPGTT), (B) increased blood glucose levels but (C) did not
change plasma insulin levels. Results are reported as the mean ± SD (n=4-7). @,
p < 0.05 compared to normal diet.
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Figure 3.28. Effects of high fat diet on liver injury and NAFLD in female mice.
This figure shows consumption of high fat diet for 24 weeks did not cause liver
injury in female mice as indicated by (A) liver: tibia ratios, (B) plasma ALT or (C)
plasma AST. However, high fat diet did induce NAFLD. (D) Representative
photomicrographs of paraffin embedded liver tissue stained with hematoxylin &
eosin staining (H&E, 200x). (E) Steatosis was scored as percent of liver cells in 5,
10x fields per liver containing fat. (F) Representative photomicrographs of Oil Red
O (neutral lipids, ×200) stained frozen liver sections. (G) Quantitative image
analysis of ORO‐positive staining performed using Image J: results are shown as
percentage of microscope field. (H) Biochemical quantification of hepatic
triglycerides. Results are reported as the mean ± SD (n=5-8). @, p < 0.05
compared to normal diet.
94

normal diet (Figure 3.28H). Taken together, these results indicate our high fat diet
model was successful in inducing weight gain and altering blood glucose levels
while the measures of steatosis and hepatic triglycerides suggest high fat diet may
be inducing NAFLD.

Characterization of the cadmium exposure model
Next we set forth to confirm the success of our cadmium exposure model in
female mice. Epidemiologically, women generally have greater cadmium retention
than men (Vahter et al., 2002; Vahter et al., 2007) and we have previously shown
cadmium accumulates in the liver of female mice (Young et al., 2019). As
expected, in female mice fed a normal diet, cadmium accumulated in the liver in a
concentration-dependent manner. Compared to unexposed mice, hepatic
cadmium concentrations were 14- and 320-times greater in mice exposed to 0.5
and 5 ppm cadmium, respectively (Figure 3.29A). Very similar values were seen
in mice fed high fat diet with the exception of those exposed to 0.5 ppm cadmium.
Compared to normal diet fed mice, hepatic cadmium concentrations in HFD mice
exposed to 0.5 ppm cadmium were only about 7-times great than that of
unexposed mice, almost half the cadmium found in the corresponding cohort fed
a normal diet (Figure 3.29A).
As female mice were exposed to cadmium in their drinking water, we
measured water consumption and calculated the average administered cadmium
intake (Figure 3.29B and C). Over the course of the study, 0.5 and 5 ppm cadmium
exposed female mice drank an average of 4.89 ± 1.37 and 4.51.13 ± 0.67 mL
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Figure 3.29. Hepatic cadmium levels and weekly administered cadmium
intake in female mice. This figure shows cadmium accumulated in the liver in a
concentration-dependent manner, reflecting the average administered cadmium
intake delivered by drinking water. (A). Hepatic cadmium levels measured by ICPMS. (B) Average weekly administered cadmium intake delivered by drinking water
in normal diet fed female mice. (C) Average weekly administered cadmium intake
delivered by drinking water in high fat diet fed female mice. *, p < 0.05 compared
to group control; #, p < 0.05 compared to cadmium dose within diet group.
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of water per a day, respectively, compared to controls who drank an average of
4.28 ± 0.68 mL of water per a day. Thus, independent of diet, treated female mice
drank similar amounts of water compared to controls. The average daily dose of
cadmium in female mice that drank water with 0.5 ppm cadmium was 2.45 ± 0.69
and 2.15 ± 0.46 μg in normal and high fat diet fed mice, respectively. In mice that
drank water with 5 ppm cadmium the average daily dose was significantly greater:
22.56 ± 3.33 (p = < 0.0001) and 21.95 ± 3.32 μg (p = < 0.0001) in normal and high
fat diet fed mice, respectively.

Impact of cadmium exposure on HFD-fed female mice
We next investigated the effects of whole life, low dose cadmium exposure
on high fat diet-fed female mice using the same nine measures implemented in
our model confirmation in male mice (Aim 1).

Body weight and composition
Exposure to cadmium did not alter body weight gain in normal diet or high
fat diet fed female mice (Figure 3.30A and B). In female mice that consumed
normal diet, cadmium exposure did not impact any of the parameters measured
by DEXAscan. However, there was a diet effect on % fat and lean tissue mass (p
= 0.0023 and p = 0.0053, respectively). Further multiple comparison analysis
revealed exposure to 5 ppm cadmium significantly increased % fat (Figure 3.30C)
and lean tissue mass (Figure 3.30D) in high fat diet-fed mice compared to their
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Figure 3.30. Effects of whole life cadmium exposure and high fat diet
on body weight and composition in female mice. Whole life exposure to
cadmium does not alter body weight gain over time. Body weight was measure
once a week for 24 weeks starting at weaning, continuing until sacrifice. Weekly
body weight in (A) normal diet fed male mice and (B) high fat diet fed mice.
DEXAscan was performed one week prior to sacrifice for control and 5 ppm
cadmium exposed mice to assess body composition. (C) Percent fat, (D) lean
tissue mass, (E) bone mineral density and (F) bone mineral content. Results are
reported as the mean ± SD (n=3) for DEXAscan and mean ± SEM (n=5-12) for
body weight. @, p < 0.05 compared to corresponding normal diet.
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corresponding normal diet-fed cohort, but not bone mineral density (Figure 3.30E)
or bone mineral content (Figure 3.30F).

IPGTT and plasma insulin
In normal diet-fed female mice, cadmium exposure did not alter glucose
handling, as measured by IPGTT, or plasma insulin levels (Figure 3.31A, C and
D). In female mice fed high fat diet, exposure to 0.5 ppm cadmium significantly
decreased blood sugar clearance compared to the corresponding mice fed normal
diet and these levels were similar to that of the high fat diet-fed control mice (Figure
3.31B and C). Interestingly, in mice that were fed high fat diet, exposure to the
higher concentration of cadmium (5 ppm) led to quicker blood glucose clearance
compared to mice exposed to the lower cadmium concentration (0.5 ppm) (Figure
3.31B and C). Exposure to cadmium did not impact plasma insulin levels in either
normal diet or high fat diet-fed mice (Figure 3.31D). Overall, cadmium exposure
did not significantly alter blood sugar handling or insulin levels in the plasma,
suggesting that cadmium is not significantly involved with insulin resistance in
female mice.

Hepatic injury and measures of NAFLD
In our model, diet nor exposure to 5 ppm cadmium altered liver size.
However, exposure to 0.5 ppm cadmium increased liver size in high fat diet-fed
female mice compared to exposed mice fed normal diet (Figure 3.32A).
Independent of which diet mice were fed, cadmium exposure did not change
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Figure 3.31. Effects of whole life exposure to cadmium and high fat diet on
glucose handling and plasma insulin in female mice. Whole life exposure to
cadmium does not alter high fat diet-associated changes in glucose handling in
female mice. (A) Blood glucose levels in normal diet fed mice and (B) high fat diet
fed mice after IPGTT, performed one week prior to sacrifice. (C) Integrated area
under the curve (AUC) showing quantitative changes in blood glucose levels after
glucose challenge. (D) Insulin levels in plasma at time of sacrifice. Results are
reported as the mean ± SD (n=3-7). #, p < 0.05 compared to cadmium dose within
diet group; @, p < 0.05 compared to corresponding normal diet.
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Figure 3.32. Effects of whole life cadmium exposure and high fat diet on liver
injury in female mice. This figure shows cadmium exposure does not cause liver
injury in female mice as measured by the (A) ratio of liver weight in grams to tibia
length in millimeters, (B) plasma aspartate aminotransferase (AST) or (C) plasma
alanine aminotransferase (ALT) activity. No statistical significance was observed.
Results are reported as the mean ± SD (n=6-12). @, p < 0.05 compared to
corresponding normal diet.
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Figure 3.33. Effects of whole life cadmium exposure and high fat diet on
NAFLD in female mice. This figure shows exposure to cadmium influences high
fat diet-induced steatosis. (A) Representative photomicrographs of paraffin
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embedded liver tissue stained with hematoxylin & eosin staining (H&E, 200x). (C)
Steatosis was scored as percent of liver cells in 5, 10x fields per liver containing
fat. (B) Representative photomicrographs of Oil Red O (neutral lipids, ×200)
stained frozen liver sections. (D) Image analysis of ORO‐positive staining was
performed using Image J, and results are shown as percentage of microscope
field. Results are reported as the mean ± SD (n=4-10). @, p < 0.05 compared to
corresponding normal diet.
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Figure 3.34. Effects of whole life cadmium exposure and high fat diet on
biochemical measures of NAFLD in female mice. This figure shows cadmium
exposure does not alter hepatic triglycerides or total cholesterol in in high fat diet
fed female mice. (A) Hepatic triglyceride levels. (B) Total hepatic cholesterol levels.
Results are reported as the mean ± SD (n=4-6). @, p < 0.05 compared to
corresponding normal diet.
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plasma transaminases (Figure 3.32B and C), indicating exposure to cadmium did
not induce liver injury in female mice. Histological assessment of hepatic structure
(Figure 3.33A and C) and neutral lipid staining (Figure 3.33B and D) showed a diet
effect on steatosis (p < 0.0001) and on lipid accumulation ( p = 0.0190),
independent of Similarly, independent of diet, histological assessment showed
cadmium exposure. did not change hepatic structure (Figure 3.33A and C) or alter
lipid accumulation in the liver (Figure 3.33B and D). These results were further
supported by biochemical analysis of hepatic triglycerides (Figure 3.34A) and total
hepatic cholesterol (Figure 3.34B), of which exposure to cadmium did not
influence. Taken together these data suggest cadmium exposure in female mice
did not cause liver injury. Furthermore, although consumption of a high fat diet may
induce steatosis, cadmium exposure did not alter the diet-induced hepatic
outcomes. In male mice, we saw that supplementing the diet with zinc attenuated
high fat diet-induced, cadmium-exacerbated NAFLD. Therefore we looked at the
hepatic zinc levels in female mice. Interestingly, in female mice fed high fat diet,
exposure to 5 ppm cadmium increased zinc levels by 13% compared to controls
and 16% compared to corresponding normal diet fed mice (Figure 3.35). Overall,
the increase in zinc levels may provide protection against cadmium-induced injury
in high fat diet fed female mice, as was seen in male mice supplemented with zinc.
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Figure 3.35. Hepatic zinc levels in female mice. This figure shows hepatic zinc
levels in female mice after 24 weeks of diet, post weaning, measured by ICP-MS.
Results are reported as the mean ± SD (n=5-7). *, p < 0.05 compared to group
control; #, p < 0.05 compared to cadmium dose within diet group; @, p < 0.05
compared to corresponding normal diet.
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Summary
In this aim we showed feeding female mice high fat diet for 24 weeks
increased bodyweight gain overtime and induced hyperglycemia without changing
plasma insulin levels. Although high fat diet did not cause hepatomegaly or
increase plasma transaminases, histological analysis revealed high fat diet did
cause steatosis and significantly increased hepatic triglycerides. Taken together,
these results suggest high fat diet feeding in female mice may induce NAFLD,
although the severity of the diseases appears to be much less compared to the
male mice studied in Aim 1. Our data also show that while female mice
accumulated cadmium in their livers, cadmium exposure did not act as a second
hit and did not exacerbate high fat diet-altered measure of fatty liver in female mice
as it did in the male mice nor did exposure to cadmium alone (in normal diet fed
mice) influence any of the measures investigated.
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CHAPTER 4: DISCUSSION

Overview
NAFLD is a major global public health concern accounting for more than
$103 billion dollars in annual medical costs in the United States alone (Younossi
et al 2016). The prevalence of NAFLD is rapidly growing in parallel with the
epidemic of obesity with up to 91% of obese patient’s developing liver disease
(Machado et al 2006). Interestingly, in the absence of obesity, 10-20% of the
population still develop NAFLD, suggesting the contribution of other risk factors
(Younossi et al 2018). In fact, NAFLD is a multifactorial disease in which the
pathogenesis is more accurately explained by multiple insults acting together.
Sex is a contributing factor as males are more likely to suffer from NAFLD
than females (Hyder et al 2013). Environmental exposure to the non-essential
metal cadmium may be a third contributing factor as it has been associated with
the development NAFLD in both epidemiology and animal studies (Hyder et al
2013, Go et al 2015; Ba et al 2017). However, the interaction of cadmium exposure
and consumption of a high fat diet and sex are three interactive factors in NAFLD
pathogenesis that remained unexplored until this study. We found diet, sex and
environmental exposure interact to cause NAFLD. Notably, we also found major
differences in outcome based on cadmium level. Accordingly, below we discuss
first the outcomes with 5 ppm cadmium and then with 0.5 ppm cadmium.
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Exposure to 5 ppm cadmium exacerbates high fat diet-induced NAFLD in
male mice
Sex, Cadmium, High Fat Diet and NAFLD
NAFLD is a sexually dimorphic disease occurring more often and with
greater severity in men than in women (Ballestri et al., 2017; Lonardo et al., 2019).
In general, animal models recapitulate the sex differences observed in human
populations with NAFLD (Ganz et al., 2014; Norheim et al., 2017). We found 5 ppm
cadmium exposure exacerbated high fat diet-induced weight gain, insulin
resistance, hepatic injury (hepatomegaly and plasma transaminase), steatosis and
lipid deposition in male mice and although this exposure causes greater cadmium
accumulation in the liver of females, it does not impact high fat diet-induced NAFLD
in female mice. We are the first to report these outcomes supporting our hypothesis
that cadmium exposure exacerbates high fat diet-induced NAFLD in males more
than females and supporting the multiple hit hypothesis that NAFLD prevalence
and progression is influenced by multiple variables.
The mechanisms by which cadmium exacerbates high fat diet-induced
NAFLD in male mice are uncertain and beyond the scope of this model-generating
study. Nevertheless, our data do offer some insights into possible mechanistic
directions. Data indicate a high fat diet alone can contribute to NAFLD by causing
an imbalance between lipid availability (lipogenesis/de novo lipogenesis) and lipid
removal (lipolysis and fatty acid β-oxidation) leading to excessive accumulation of
neutral lipids in the liver (Koo, 2013; Saponaro et al., 2015; Ipsen et al., 2018). For
example, Oosterveer et al (2009) showed induction of hepatic fatty acid synthesis
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in C57BL/6J male mice fed high fat diet for 6 weeks. However, other studies have
shown high fat diet supersession of de novo lipogenesis (Duarte et al., 2014). In
two separate studies in Wistar rats fed either a 42% or a 51.8% fat diet for 6 and
12 weeks, respectively, fatty acid β-oxidation levels were decreased (Lionetti et
al., 2014; Aoun et al., 2012). In contrast, consumption of both 55 and 60% high
fat diet in rodents is associated with increased fatty acid β-oxidation activity
(Cardoso et al., 2013; Satapati et al 2012). Taken together, the contradictions in
the literature exemplified the complexities of lipid metabolism. Therefore, if
cadmium were to disrupt one or both of these pathways, this may cause the
exacerbated outcome we observed.
In our study we considered cadmium disruption of sterol regulatory elementbinding protein (SREBP-1)-mediated lipogenesis as a possible mechanisms for
the cadmium exacerbation of high fat diet-induced NAFLD as SREBP-1 plays a
major role in NAFLD pathogenesis and cadmium exposure is associated with
upregulation of genes associated with hepatic lipid metabolism (Ferre and
Foufelle, 2007; He et al., 2015; Moslehi and Hamidi-zad, 2018; Zhang et al., 2018).
SREBP-1 increases the rate of fatty acid synthesis though transcriptional activation
of lipogenic enzymes such as fatty acid synthase (FASN) and stearoyl coenzymeA desaturase1 (SCD1) (Fon Tacer and Rozman, 2011), both of which are found to
have increased expression in NAFLD patients (Kohjima et al., 2007; Kotronen et
al., 2009). In animal studies, overexpression of SREBP-1 resulted in increased
lipogenesis and fatty liver (Shimano et al 1997) while inactivation of the SREBP-1
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gene in an obese mouse model reduced total triglycerides by half (Park et al.,
2014).
However, in our model, consumption of high fat diet with or without cadmium
exposure did not trigger a SREBP-1 mediated increases in lipid synthesis in male
mice, but actually a decrease in its downstream targets FASN and SCD-1,
indicating increased de novo lipogenesis is likely not a factor. As it relates to our
results in unexposed mice fed a high fat diet, this outcome is consistent with some
of the literature showing high fat diet actually suppresses de novo lipogenesis
(Duarte et al., 2014). The literature surrounding cadmium exposure and SREBP-1
is sparse and data associating cadmium with upregulation of hepatic lipid
metabolism genes was obtained at cadmium concentrations much greater than
was used in our model (2- and 20-fold higher compared to our highest exposure
level) (Zhang et al., 2018).
Another mechanism by which cadmium may exacerbate high fat dietinduced NAFLD is through disruption of β-oxidation. However, we did not consider
this pathway in our model. Data concerning cadmium interacting with fatty acid βoxidation are very limited. In Chinese toads (Bufo gargarizans) exposure to low
levels of cadmium did not affect fatty acid β-oxidation, whereas exposure to higher
levels of cadmium resulted in reduced fatty acid β-oxidation (Wu et al., 2017). In
another recent study, environmental cadmium exposure for 20 weeks inhibited
fatty acid oxidation, possibly through the sirtuin 1 (SIRT1) pathway (He et al.,
2019). Given the absence of effect on lipogenesis, this pathway will be an
important future consideration for our model.
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In contrast to the lipogenesis data, we did find a strong effect on
metallothionein. The interactions of cadmium with high fat diet we found in male
mice are consistent with studies showing cadmium interacts with a western high
fat diet to disrupt the general dysregulation of essential metal homeostasis
associated with obesity (Garcia et al., 2009; Young et al., 2019). Metallothionein
plays a major role in the homeostatic regulation of essential metals (Sakulsak,
2012) and animal studies have shown metallothionein has the potential to prevent
obesity and obesity related disease (Sato et al., 2013; Byun et al., 2011; Lindeque
et al., 2015; Kawakami et al., 2019). In fact, metallothionein knockout mouse
strains are more susceptible to high fat diet-induced effect (Lindeque et al., 2015;
Gu et al., 2107). Taken together it is likely that cadmium and high fat diet interact
to reduce metallothionein induction, resulting in increased susceptibility to both
cadmium and high fat diet insult.
Indeed, we also found high fat diet suppresses metallothionein induction in
the presence of cadmium. Our data show, in mice fed normal diet, 5 ppm cadmium
increased mRNA and protein levels of hepatic metallothionein. However, in high
fat diet-fed mice, 5 ppm cadmium exposure dramatically lowered metallothionein
response compared to normal diet-fed mice, indicating a possible interaction
between high fat diet and cadmium that hinders the protective response of
metallothionein, suggesting a possible mechanism by which exposure to cadmium
may exacerbate high fat diet-induced liver disease.
The sexually-dimorphic outcome of our results may be explained by
differential regulation of zinc homeostasis in males and females. For example, high
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serum zinc levels are associated with increased risk of developing metabolic
syndrome in men, while similar zinc levels appear to be protective in women
(Ghasemi et al., 2014). Additionally, studies have shown differential expression of
zinc transporters (Foster et al., 2011) in men and women. In our study we show
hepatic zinc levels were unchanged in male mice regardless of diet or cadmium
exposure. However, in female mice fed high fat diet, exposure to 5 ppm cadmium
significantly increased hepatic zinc levels. In fact, these levels were similar to those
reported in the male mice in our study after zinc supplementation. The importance
of zinc status in our model will be discussed in detail below. Another explanation
or our sexually-dimorphic results are hormones, in particular estrogen. However,
we have yet to explore this in our model. Both epidemiological and experimental
studies highlight the protective role of estrogens against metabolic diseases,
including NAFLD, at least before menopause (Lonardo et al., 2019; Tramunt et al.,
2020).
Furthermore, in models of high fat diet-induced obesity, estrogen driven
protection is abolished by bilateral ovariectomy and this protection is restored upon
administration of estrogen (Handgraaf et al., 2013; Riant et al., 2009). Even in male
mice, administration of estrogen even protected male mice from obesity
complications (Dakin et al., 2015). In addition, cadmium exhibits both estrogenic
and androgenic properties and thus is regarded as a potential endocrine disrupter
and may, in part, explain the sex-specific differences of cadmium exposure on
diseases outcome, including NAFLD (Vahter et al., 2007; Nasiadek et al., 2018).
Taken together, the estrogenic effects of cadmium will be important to consider in
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our model and may help further elucidate the underlying mechanism responsible
for the sexual dimorphism in our model.

Sex, Cadmium and NAFLD
Epidemiologically, cadmium burden is associated with liver-related
mortalities and NAFLD (Hyder et al., 2013). Thus, we considered the ability of
cadmium alone to induce NAFLD. We found exposure to 5 ppm cadmium, starting
in utero and continuing for 24 weeks post weaning, did not induce NAFLD, though
we did find increased levels of liver transaminases (ALT and AST) in cadmium
exposed mice independent of diet.
Our data conflict with the only other previous in vivo report of cadmium and
NAFLD, which reported cadmium exposure induces hepatotoxicity and
dysregulates NAFLD-related metabolic pathways (Go et al., 2015). That study
exposed 8 week-old male mice for 20 weeks to 10 ppm cadmium in drinking water.
Consistent with our study, they found both ALT and AST were elevated, but they
also found liver triglycerides and lipid deposition were also elevated, which were
not found in our study. The difference is most likely due to the fact that the cadmium
exposure they used was twice the exposure we used in our study. This possibility
would suggest the changes in ALT and AST may precede the changes in lipid
deposition and hepatic triglycerides following cadmium exposure. Heavy metals,
and cadmium in particular, are associated with elevated ALT and AST activity
(Kang et al., 2013; Rao et al., 2017) and these elevations have been found in
otherwise healthy adults (Kang et al., 2013). Therefore it is possible that the levels
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of cadmium in both studies was sufficient to increase transaminase levels, but in
our study, the lower concentration of cadmium was not sufficient to cause
progression to NAFLD.
It is also notable that mice in our study were exposed to cadmium starting
in utero whereas in the study by Go et al (2015) mice were not exposed to cadmium
until they were 8 weeks old as the authors stated in their methods that they
specifically chose 8 week old mice as their intention was not to assess
developmental toxicity. Thus, it is possible the chronicity of the exposure may have
played a role in these different outcomes. For example, it is well documented that
prenatal cadmium exposure is associated with altered DNA methylation patterns
(Castillo et al., 2012; Kippler et al., 2013; Mohanty et al., 2015). Castillo et al.
(2012) reported altered methylation patterns of the hepatic glucocorticoid receptor,
a phenomenon linked to increased risk of cardiometabolic disorders in adulthood.
However, the consequences of these early life, cadmium-induced altered DNA
methylation patterns on the development of diseases later in life is largely
unknown. Therefore, an interesting future course for our model would be to
investigate the impact of early-life cadmium exposure and altered DNA methylation
patterns on the development of high fat diet-induced NAFLD.
Our data support the literature that cadmium accumulates in the liver in a
concentration-dependent manner and this burden is much greater in females
compared to males (Vahter et al., 2002; Vahter et al., 2007; Young et al., 2019).
Historically, the health effects related to cadmium were thought to be more
common among women than men. However, in addition to these ideas being
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driven by observation of greater cadmium body burden in women, they were also
formulated based on the epidemiology of Itai-itai disease. Appearing in Japan after
World War II due to consumption of cadmium-contaminated rice, Itai-itai disease,
which effects the kidneys and bones, was found almost exclusively in elderly multiparous women (Nogawa and Kido, 1996; Ogawa et al., 2004). As such, these
studies rarely considered menopause or age-specific sex differences. In fact, in a
recent in vivo study Go et al (2015) actually argued that because females absorb
cadmium to a greater degree than males, any observation in the males should be
either worse or replicable in females and therefore, using only males in their study
was acceptable.
By contrast, studies that have taken these factors into consideration show
pre-menopausal women have a lower prevalence and incidence of NAFLD
compared to men despite having a greater cadmium body burden (Long et al.,
2018; Lonardo et al., 2019). Epidemiologically, environmental cadmium exposure
is associated with necroinflammation, but not NAFLD in women (Hyder et al.,
2013). A study in CD1 female mice showed subchronic exposure to cadmium
resulted in upregulated mRNA levels of hepatic lipid metabolism genes but did not
result in insulin resistance or lipid accumulation in the liver (Zhang et al., 2017).
Similarly, in our study we found whole life exposure to cadmium did not result in
insulin resistance or cause hepatic lipid deposition.
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Zinc supplementation rescues cadmium exacerbated, high fat diet-induced
NAFLD
Discovering that whole life cadmium exposure interacts with diet to
exacerbate NAFLD in male mice, we sought to determine if zinc supplementation
could ameliorate the outcome. Zinc is an essential trace element that plays a
critical role in various physiological processes, including glucose and lipid
metabolism (Olechnowicz et al., 2018; Zhang and Cai, 2020). Thus, several
studies have looked at the interactions between obesity and zinc homeostasis.
Epidemiologically, serum zinc levels are significantly decreased in obese patients
(Peraza et al., 1998; de Luis et al., 2013; Suliburska et al., 2013) and low nutritional
zinc status is associated with insulin resistance and an altered lipid profile
(Costarelli et al., 2010). These results are supported by animal studies showing
zinc deficiency worsens disease outcomes associate with high fat diet and obesity
while zinc supplementation alleviates such outcomes (Wang et al., 2016; Luo et
al., 2016; Chen et al., 2016; Cooper-Capetini et al., 2017; Qi et al., 2020).
We found zinc supplementation tended to alleviate high fat diet associated
insulin resistance, liver injury and hepatic lipid deposition, but not body weight gain.
These findings are consistent with the results reported by Qi et al (2020) that found
zinc supplementation (90 mg/kg zinc) given to mice fed a 60% kcal fat diet for 6
weeks did not alter body weight gain over time. In contrast zinc supplementation
significantly reduced % fat mass, of which we did not observe in our study.
Furthermore, Qi et al (2020) showed much greater decreases in hepatic
triglycerides and the percent areas stained with oil red O then we observed in our
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model. The variance in the degree of zinc supplemented-rescue between our
model and the model reported by Qi and colleagues may be explained by the
differences is the duration of the studies (6 weeks vs. 24 weeks) and the age at
which the mice were provided both the high fat and zinc supplemented diets (3
weeks vs. 8 weeks). However, it is clear from both studies that zinc
supplementation can attenuate high fat diet-induced liver disease.
As part of the characterization of our model, we investigated the impact of
zinc supplementation on hepatic expression of metallothionein, as this cysteine
rich, small molecular weight molecule also plays a critical role in zinc homeostasis
(Baltaci et al., 2018). Additionally, zinc supplements are thought to, in part, have
their effect by inducing the synthesis of metallothionein (Peraza et al., 1998). Our
lab has shown zinc supplementation increased cardiac expression of
metallothionein in mice fed normal diet (Wang et al., 2017). However in our current
study, zinc supplementation did not change hepatic zinc levels, nor did it induce
synthesis of hepatic metallothionein in normal diet fed mice. Interestingly, zinc
supplementation has been shown to induce metallothionein in the intestine, which
then binds to divalent cations, such as zinc, inhibiting the degree of intestinal
uptake and subsequent disruption to other tissues (Brewer et al., 1994;
Hoogenraad, 2006). Therefore, in our current model, it is possible that in normal
diet fed mice, the additional dietary zinc did not make its way to the liver and
therefore did not induce hepatic metallothionein.
In stark contrast, in high fat diet-fed mice, metallothionein mRNA levels
were approximately 50-times greater in animals whose diets were supplemented
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with zinc. Furthermore, these results translated to significant increases in
metallothionein protein levels which were approximately 17-times greater in zinc
supplemented animals fed high fat diet. These results suggest high fat diet creates
an

environment

in

which

dietary

zinc

supplementation

can

increase

metallothionein synthesis and are in line with the various studies showing zinc
supplementation increases the expression of metallothionein in the tissues of
obese animals and subsequent protection from high fat diet-induced diseases
(Hennigar et al., 2016; Wang et al., 2017; Olechnowicz et al., 2018).
We found exposure to 5 ppm cadmium increases the severity of high fat
diet-induced NAFLD in male mice and were able to rescue this phenotype by
supplementing the diet with zinc and significantly decreasing hepatomegaly,
plasma ALT levels, steatosis, lipid deposition and hepatic triglycerides. Indeed, the
toxic effects of cadmium are highly influenced by zinc status in the body (Brzóska
and Moniuszko-Jakoniuk, 2001). Diets deficient in zinc increase cadmium body
burden and toxicity (Waalkes et al 1991) while numerous data in laboratory
animals indicate the addition of zinc protects against the adverse of effects of
cadmium-induced liver injury (Khan et al., 1991; Kudo et al., 1991). We, as well as
others, have shown zinc supplementation attenuates high fat diet-induced
outcomes (Wang et al., 2016; Luo et al., 2016; Chen et al., 2016; Cooper-Capetini
et al., 2017; Qi et al., 2020). However, this is the first study to show zinc
supplementation can rescue a cadmium-exacerbated, high fat diet induced
NAFLD.
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Our data further suggest zinc supplementation may act through induction of
metallothionein to attenuate the consequences of consuming a high fat diet. In high
fat diet fed mice, zinc supplementation resulted in increased metallothionein levels
(both mRNA and protein) in 5 ppm cadmium exposed mice, although the degree
of induction was less than what was seen in the high fat diet fed control mice.
Overall, these data implicate the use of zinc supplementation as a possible
therapeutic for NAFLD, which may in part act by targeting metallothionein.

Exposure to 0.5 ppm cadmium rescues high fat diet-induced NAFLD in male
mice
Unexpectedly, and in contrast with our observation that whole life exposure
to 5 ppm cadmium exacerbated high fat diet-induced NAFLD, exposure to 0.5 ppm
cadmium actually rescued NAFLD induced by high fat diet in male mice. In fact,
after 24 weeks of being fed high fat diet, mice exposed to 0.5 ppm cadmium had
a marked decrease in body weight compared to high fat diet controls that continued
until sacrifice. The reduced weight gain was further reflected in improved glucose
handling and decreased insulin in the plasma, similar to levels seen in normal diet
fed animals. This outcome was not seen in females.
The literature in support of cadmium as a therapeutic is virtually nonexistent. However, there are a few studies that have exploited cadmium’s adverse
effects on cell proliferation and the immune system in the treatment of rheumatoid
arthritis (Ansari et al., 2015; Bonaventura et al., 2017). Interestingly, Ansari et al
(2015) showed exposure to 5 ppm cadmium chloride in drinking water restored
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antioxidant levels, arrested progression of the autoimmune disease and downregulated pro-inflammatory modulators whereas exposure to 50 ppm cadmium
chloride had the complete opposite effect, increasing the pro-inflammatory
response and exacerbating the disease. These results are particularly interesting
in that the outcomes at one concentration of cadmium are very different than the
outcomes at a 10 times greater concentration – a phenomenon similar to what we
observed in our study. Therefore, in our model, the effects of inflammation on
NAFLD progression is an important future consideration.
The capacity of cadmium to mimic essential metals may, in part, explain the
rescuing effect of 0.5 ppm cadmium in high fat diet-induced NAFLD. Obese
individuals have high rates of micronutrient deficiency, despite the excessive
intake of food and such deficiencies may contribute to the development of high fat
diet-induced disease (Garcia et al., 2009; Via et al., 2012). It is possible that
exposure to cadmium at this lower concentration of 0.5 ppm sufficiently acts to
seemingly restore the micronutrient deficiency through molecular mimicry and thus
reduce the effect of high fat diet. However, further studies would need to be
conducted to examine micronutrient status in these animals as well as the long
term, later life implications for such an exposure.
The observed protection from high fat diet outcomes may also be explained
by metallothionein levels. In normal diet-fed mice, exposure to 0.5 ppm cadmium
did not provoke metallothionein synthesis. However, in mice fed high fat diet both
mRNA and protein levels of metallothionein increased after exposure to 0.5 ppm
cadmium, compared to both controls and 5 ppm cadmium exposed mice. As
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metallothionein plays a major role in essential metal homeostasis, its induction
may help elevate high fat diet-associated nutrient deficiencies and thus prevent
obesity related diseases. Indeed, animal studies implicate metallothionein in
obesity prevention, but the mechanisms remain unclear (Sato et al., 2013; Byun et
al., 2011; Lindeque et al., 2015; Kawakami et al., 2019).
It is also worth mentioning that in high fat diet fed mice exposed to 0.5 ppm
cadmium, both Srebf-1 mRNA and mature SREBP-1 protein levels were higher
compared to controls suggesting the protective effect of 0.5 ppm cadmium on high
fat diet-induced NAFLD may be in part due to alterations in SREBP-1 mediated
lipogenesis. However, the observed increases in SREBP-1 levels were not
reflected in the mRNA of Fasn or Scd-1. Thus, further investigation is needed to
determine the involvement of SREBP-1 in the protective mechanism of 0.5 ppm
cadmium.

Whole life exposures
Cadmium and sex
Although cadmium exposure is associated with the development of several
metabolic diseases, such as NAFLD, these studies did not take into account such
environmental exposures can be life-long and multigenerational nor did they take
into account risk of developing adulthood diseases is correlated with adverse
stimuli in utero, resulting in permanent physiological and metabolic changes.
Furthermore, although low level, prenatal cadmium exposure is strongly
associated with non-lethal birth outcomes, the impact of these early life exposures
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on the development of diseases later in life remain elusive (Young and Cai, 2020).
Therefore, our model of whole life exposure to cadmium, starting in utero and
continuing through adulthood, provides unique insights into disease initiation and
progression.
To date, one other study has investigated the impact of early life exposure
to cadmium on hepatic lipid metabolism and fat accumulation in adulthood. Ba et
al (2017) exposed both male and female mice to 100 nM (18 ppb) cadmium
chloride in drinking water, starting in utero and continuing until 16 weeks postweaning and found a significant increase in body fat, liver triglycerides and lipid
deposition in male, but not female mice (Ba et al., 2017). Although the exposure
paradigm used by Ba and colleagues (2017) does resemble our study, we obtained
very different results. In our study, as mentioned above, cadmium exposure did
not alter body composition or measurements of NAFLD in male or female mice.
Importantly, in the study performed by Ba et al. (2017), mice were fed
standard laboratory rodent diets with no explanation of the diet composition. These
standard rodent diets can vary greatly from batch to batch due to the natural
fluctuation of growing seasons and harvest locations of the plant materials used to
make the diet (Ricci and Ulman, 2005). Such fluctuations include content of heavy
metals, such as cadmium. In fact, cadmium contamination ranging from 30-100
ppb was found in 13 laboratory rodent diets from 5 different continents (Mesnage
et al., 2015). Therefore, the mice in the study were likely exposed to much higher
levels of cadmium than provided in the drinking water. The mice in our model were
fed purified diets in order to avoid such confounding factors.
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High fat diet and sex
In line with the “multiple hit” hypothesis of NAFLD progression, the role of
diet-environment interaction in the initiation, progression and development of
human metabolic diseases is of growing interest. Animal studies have been
published investigating the relationship between diet and low level cadmium
exposure, showing that the combination of high fat or high cholesterol diets with
cadmium exposure results in increased risk of heart failure and altered bone quality
(Türkcan et al., 2015; Zhang et al., 2020). However, in addition to absence of
studies investigating diet-cadmium interactions in liver disease, previous studies
start their diet regime when rodents are 6 or 8 weeks old, which is comparable to
an 11.5 and 20 year old human, respectively. Therefore, these studies do not take
into consideration that obesity can start at a much younger age. In fact, in 2016
the incidence of obesity in children between the ages of 2-5 in the United States
was 13.9% and at least 25% of these children are at risk for remaining obese into
adulthood (Sanyaolu et al., 2019). In our model, mice were started on high fat diet
when they were weaned, at 3 weeks of age (~ 6 month old human), thus taking
into consideration exposure to diets high in fat can occur early in life and continue
through adulthood.
In male mice, consumption of a high fat diet for 24 weeks, starting at 3
weeks of age resulted in increased body weight, percent fat, lean tissue mass, and
blood glucose and plasma insulin levels. Furthermore, this high fat diet feeding
regime resulted in hepatomegaly, increased levels of plasma ALT, steatosis and
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increased hepatic triglycerides. Our results are consistent with other high fat dietinduced models of NAFLD in male (Nakamura and Terauchi, 2013; Recena Aydos
et al., 2019; Velázquez et al., 2019)
In our model, consumption of high fat diet did not trigger a SREBP-1
mediated increase in lipid synthesis in male mice. In fact, in our model, high fat
diet decreased two rate limiting lipogenic enzymes, suggesting an overall decrease
in SREBP-1-mediated in lipid synthesis. Our results contradict the existing
literature (Biddinger et al., 2005; Buettner et al., 2006) that show high fat-diet
increases SREBP-1-mediated lipid synthesis. For example, in male mice fed a high
fat diet (55% calories from fat) for 18 weeks starting at 6 weeks of age, activation
of SREBP-1 and SCD-1 transcript levels and activity were increased (Biddinger et
al., 2005). Similarly, in male rats fed a western diet (42% calories from fat) for 12
weeks, also starting at 6 weeks of age, Buettner and colleagues (2006) found an
upregulation of hepatic SREBP-1c-dependent genes.
Our outcomes in male animals exposed to high fat diet alone are consistent
with these previous reports, thus the reason for the discrepancies in levels of
SREBP-1 and its downstream lipogenic targets between our results and the
existing literature is uncertain. One explanation may be the length of the study
and the age at which the animals were given access to high fat diet. In the previous
studies, animals were started on a high fat diet at 6 weeks of age, in contrast, in
our model, the pups were moved onto a high fat diet at the time weaning
(approximately 3 weeks of age). Although a difference of 3-5 weeks may not seem
like a long time, in “mouse days” it can be the difference between puberty and
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adulthood. A 3, 6, and 8-10 week old mouse is comparable to a 6 month old, 11.5
year old, and 20 year old human, respectively (Dutta and Sengupta, 2016).
Therefore, age-induced metabolic changes may account for these discrepancies.
However the data supporting age-related discrepancies under the age of 20 are
few as most of them examine the differences between adults of reproductive age
and elderly populations (Roberts et al., 2006). One study, in humans, did examine
incidence of obesity-induced metabolic syndrome and found increases with age
from 3% to 9% in adolescents ages 13 and 19, respectively (Sinaiko et al., 2005).
In females, we showed 24 weeks of high fat diet feeding increased
bodyweight gain, percent fat and induced hyperglycemia without changes in
plasma insulin levels in female mice. These results were similar to those found in
a study by Pettersson et al (2012) who showed 14 weeks of high fat diet feeding
in female mice caused weight gain and impaired glucose tolerance, while normal
serum insulin concentrations were maintained. We further showed that although
measures of hepatic injury were not altered as a result of high fat diet consumption,
lipid deposition and hepatic triglycerides were increased, indicating our high fat
diet model induced steatosis. These results are consistent with a study by Ganz et
al (2014) who found 16 weeks of high fat diet feeding resulted in increased hepatic
triglycerides and steatosis, but no change in plasma ALT levels in female mice.
Taken together, our study extends the field to show whole life exposure to
cadmium does not induce NAFLD in female animals, which recapitulates the
disease etiology seen in human populations.
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Limitations
While the results from this study provide critical insight into the “multiple-hit”
nature of NAFLD, considering diet, environmental exposures and sex as
contributing variables there are several limitations in this study. First, due to
budgetary restraints, DEXAscans were not performed on mice exposed to 0.5 ppm
cadmium as we originally expected that the greatest effect would be with 5 ppm
cadmium, and to a lesser degree 0.5 ppm exposure. We however did not anticipate
the stark, opposite outcomes between the two cadmium exposures. Therefore,
additional information of effects on body mass composition in 0.5 ppm cadmium
exposed mice would be informative. Furthermore, this study only investigates the
impact of two concentrations of cadmium in disease outcome, thus not providing
an informative dose response curve. Additional cadmium exposures would
possibly provide valuable insight into the opposing cadmium effects we observed
in our model. Another limitation is the number of animals in the study. In some of
the exposure groups there was a small number of animals, therefore statistical
power was low in these groups. A greater number of animals per a group would
possibly clarify some of the observed variability in the model.
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Future Directions
While studies have looked at the impact of diet and cadmium exposure as
independent variables, our study is among the first to investigate how these two
factors may act together to influence initiation and progression of NAFLD. Our data
show that while in male mice exposure to 5 ppm cadmium exacerbated high fat
diet-induced NAFLD and exposure to 0.5 ppm cadmium reversed the phenotype,
in female mice cadmium exposure did not alter the observed high fat diet
associated outcomes. Further investigation is needed to understand the underlying
mechanism responsible for the sexual dimorphism in our model, leading the way
to more target therapies. Indeed, there is evidence that cadmium has estrogenic
effects and can act as an endocrine disrupter (Vahter et al., 2007; Nasiadek et al.,
2018) so it would be interesting to perform our study in ovariectomized mice.
Furthermore, our data show zinc levels in high fat diet fed female mice are
increased in response to cadmium exposure, a possible mechanism by which
females were protected from the cadmium-exacerbated, high fat diet effects
observed in male mice. Therefore, it would be of interest to introduce a zinc
deficient diet into our exposure model to determine 1) does zinc deficiency in
female mice increase their susceptibility to cadmium-altered NAFLD and 2) does
zinc deficiency in male mice result in further exacerbation or altered NAFLD
pathogenesis?
Our data show the mechanism by which 5 ppm cadmium exacerbates high
fat diet-induced NAFLD was not through altered de novo lipogenesis; however, we
did not look at the other side of the lipid metabolism pathway, fatty acid β-oxidation.
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Although there are limited data implicating cadmium’s ability to alter the breakdown
of fatty acids, it would be important to investigate the contribution of this pathway
to the pathology observed in this study.
To our surprise, our data show exposure to 0.5 ppm cadmium recues high
fat-induced NAFLD. The mechanism of cadmium-associated disease recovery
undoubtedly deserved further investigation. As such, future studies may include
investigating the role of cadmium and inflammation in NAFLD pathogenesis. This
future direction is based on a report showing exposure to 5 ppm cadmium stopped
the progression of rheumatoid arthritis by restoring antioxidant levels and downregulating the pro-inflammatory response (Ansari et al., 2015).
Lastly, in addition to the liver, our model included the collection of other
metabolic organs, providing for the opportunity to investigate organ crosstalk in
disease development. Of particular interest to our lab is the cross-talk between the
liver and the heart. Interestingly, cardiovascular diseases are the most common
cause of mortality in patients with NAFLD (Targher et al., 2010). Furthermore, we
have recently shown the combination of chronic cadmium exposure and high fat
diet result in cardiac remodeling (Liang et al., 2019). However, the impact of
cadmium-altered, high fat diet-induced NAFLD and the subsequent increased risk
of CVD has not been investigated.
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APPENDIX I

Chapters 1, 3 and 4 of this dissertation contain modified content from Young and
Cai, 2020 and Young et al., 2018. Rights for use are below in captured screen
shots.

154

LIST OF ABBREVIATIONS

ALT

Alanine aminotransferase

AST

Aspartate aminotransferase

AUC

Area under the curve

BMC

Bone mineral content

BMD

Bone mineral density

CaT1

Channel-like calcium transport

Cd

Cadmium

cDNA

Complementary DNA

CVD

Cardiovascular disease

DEXA

Dual energy X-ray absorptiometry

DMT-1

Divalent metal transporter 1

DNA

Deoxyribonucleic acid

FASN

Fatty acid synthase

GAPDH

Glyceraldehyde 3-phosphate dehydrogenase

GSH

Glutathione

H&E

Hematoxylin & eosin

HFD

High fat diet

IPGTT

Intraperitoneal glucose tolerance test
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mRNA

Messenger RNA

MT

Metallothionein

MTP1

Metal transporter 1

NAFL

Nonalcoholic fatty liver

NAFLD

Nonalcoholic fatty liver disease

NASH

Nonalcoholic steatohepatitis

ND

Normal Diet

NPL

National Priority List

ORO

Oil red O

PPB

parts per billion

PPM

parts per million

SCD1

Stearoyl coenzyme-A desaturase1

SD

Standard Deviation

SEM

Standard error of the mean

SREBP

Sterol regulatory element-binding protein

ZIP

Zrt- and Irt-like protein

Zn

Zinc
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of Louisville

Meetings Attended
2008 Annual Meeting for the American Association for Cancer Research
Toxics and Tomorrow’s Children – University of Southern Maine
Thinking Matters - University of Southern Maine
2009 Annual Meeting for the Society of Toxicology
Thinking Matters - University of Southern Maine
36th Biological and Medical Science Symposium
Annual Meeting of the Northeast Regional Chapter of the Society of
Toxicology
2015 54th Annual Meeting for the Society of Toxicology
5th Georgian Bay International Conference on Bioinorganic Chemistry
46th Annual Meeting of the Environmental Mutagenesis and Genomics
Society
Research!Louisville– University of Louisville
21st Biennial Meeting of the Society of Marine Mammalogy
2016 55th Annual Meeting of the Society of Toxicology
47th Annual Meeting of the International Association for Aquatic and Animal
Medicine
Research!Louisville– University of Louisville, October 2016
2017 56th Annual Meeting of the Society of Toxicology
Research!Louisville – University of Louisville, September 2017
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Annual Meeting, Ohio Valley Chapter of the Society of Toxicology,
December 2017
2018 57th Annual Society of Toxicology Meeting, March 2018
Graduate Student Regional Research Conference, March 2018
Research!Louisville – University of Louisville, October 2018
10th Conference on Metal Toxicity & Carcinogenesis, October 2018
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology,
November 2018
2019 58th Annual Society of Toxicology (SOT) Meeting, Baltimore March 2019
The 15th International Congress of Toxicology (ICTXV), Hawaii July 2019
13th Conference of the International Society for Trace Element Research in
Humans (ISTERH) Bali, Indonesia, September 2019
Research!Louisville – University of Louisville, September 2019
Annual Meeting, Ohio Valley Chapter of the Society of Toxicology, October
2019
Annual National Institute of Environmental Health Sciences Superfund
Research Program Meeting in Seattle, Washington November 2019.
World Marine Mammal Conference in Barcelona, Spain December 2019
2020 OVSOT Student & Postdoctoral Researchers’ Virtual Summer Meeting July
2020 (Organizer)
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3. Xie, H., Holmes, A.H., Wise, S.S., Young, J.L., Wise, J.T.F. and Wise, Sr.,
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Book Chapters
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